Abstract
When one tries to give an account of the action of neuroleptic agents on neurons in the central nervous system, it seems reasonable to start from the principle that drugs such as reserpine or CPZ impair impulse transmission at synapses where monoamines act as transmitter substances. Reserpine depletes NA from sympathetically innervated tissues (for literature see Carlsson et al., 1957b; Carlsson, 1966), and diminishes or abolishes the effect of electrical or chemical stimulation of adrenergic nerves due to lack of the transmitter (Bertler et al., 1956; Bertler et al., 1958; Muscholl and Vogt, 1957, 1958, Trendelenburg and Gravenstein, 1958). There is better time correlation between the depression of adrenergic impulse transmission and a reduced tissue uptake of NA than between the disturbed nerve function and the reduced NA levels in the tissues (Andén et al., 19641). Similarly, reserpine decreases the content of NA, DA, and 5HT in the brain and spinal cord (Shore and Brodie, 1957; Shore et al., 1957; Carlsson, 1959,1965; Andén et al., 1967b) and inhibits the accumulation of NA in the brain when the amine is administered into the lateral ventricles (Glowinski and Axelrod, 1965, 1966). It is now generally accepted that changes in central nervous functions produced by reserpine are due to lack of the monoamines as transmitters (Carlsson, 1964), i.e., reserpine acts presynaptically in inhibiting monoaminergic impulse transmission. However, there is considerable disagreement when an attempt is made to correlate central effects in terms of changes in animal behavior with the impairment of the function of a particular monoaminergic transmitter.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aghajanian, G.K., Bunney, B.S.: Central dopaminergic neurons: neurophysiological identification and responses to drugs. In: Frontiers in Catecholamine Research, Snyder, S.H., Usdin, E., Eds., pp. 643–648, Pergamon Press, New York (1973)
Aghajanian, G.K., Bunney, B.S.: Dopamine “autoreceptors”: pharmacological characterization by microionotophoretic single cell recording studies. Naunyn Schmiedebergs Arch. Pharmacol. 297, 1–7 (1977)
Agid, Y., Guyenet, P., Glowinski, J., Beaujouan, J.C., Javoy, F.: Inhibitory influence of the nigrostriatal dopamine system on the striatal cholinergic neurons in the rat. Brain Res. 86, 488–492 (1975)
Ahlman, H., Grillner, S., Udo, M.: The effect of 5-HTP on the static fusimotor activity and the tonic stretch reflex of an extensor muscle. Brain Res. 27, 393–396 (1971)
Ahn, H.S., Gardner, E., Makman, M.H.: Anterior pituitary adenylate cyclase: stimulation by dopamine and other monoamines. Eur. J. Pharmacol. 53, 313–317 (1979)
Andén, N.-E.: Antipsychotic drugs and catecholamine synapses. J. Psychiatr. Res. 77, 97–104 (1974)
Andén, N.-E., Bédard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)
Andén, N.-E., Stock, G.: Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J. Pharm. Pharmacol. 25, 346–348 (1973)
Andén, N.-E., Lundberg, A., Rosengren, E., Vyklicky, L.: The effect of DOPA on spinal reflexes from the FRA (flexor reflex afférents). Experientia 79, 654–655 (1963)
Andén, N.-E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.-Å., Larsson, K.: Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci. 3, 523–530 (1964a)
Andén, N.-E., Carlsson, A., Hillarp, N.-Â., Magnusson, T.: 5-Hydroxytryptamine release by nerve stimulation of the spinal cord. Life Sci. 3, 473–478 (1964 b)
Andén, N.-E., Häggendal, J., Magnusson, T., Rosengren, E.: The time course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta Physiol. Scand. 62, 115–118 (1964c)
Andén, N.-E., Jukes, M.G.M., Lundberg, A.: Spinal reflexes and monoamine liberation. Nature 202, 1222–1223 (1964d)
Andén, N.-E., Jukes, M.G.M., Lundberg, A., Vyklicky, L.: A new spinal flexor reflex. Nature 202, 1344–1345 (1964 e)
Andén, N.-E., Magnusson, T., Waldeck, B.: Correlation between noradrenaline uptake and adrenergic nerve function after reserpine treatment. Life Sci. 3, 19–25 (1964f)
Andén, N.-E., Roos, B.-E., Werdenius, B.: Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158 (1964g)
Andén, N.-E., Carlsson, A., Hillarp, N.-Â., Magnusson, T.: Noradrenaline release by nerve stimulation of the spinal cord. Life Sci. 4129–132 (1965a)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci. 4, 1275–1279 (1965b)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Further evidence for the presence of nigro-neostriatal dopamine neurons in the rat. Am. J. Anat. 116, 329–334 (1965c)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol. Toxicol. 24, 263–274 (1966 a)
Andén, N.-E., Dahlström, A., Fuxe, K., Olson, L., Ungerstedt, U.: Ascending noradrenaline neurons from the pons and the medulla oblongata. Experientia 22, 44–45 (1966 b)
Andén, N.-E., Dahlström, A., Fuxe, K., Olson, L., Ungerstedt, U.: Ascending monoamine neurons to the telecephalon and diencephalon. Acta Physiol. Scand. 67, 313–326 (1966 c)
Andén, N.-E., Jukes, M.G.M., Lundberg, A.: The effect of DOPA on the spinal cord. 2. A pharmacological analysis. Acta Physiol. Scand. 67, 387–397 (1966 d)
Andén, N.-E., Jukes, M.G.M., Lundberg, A., Vyklicky, L.: The effect of DOPA on the spinal cord. 1. Influence on transmission from primary afferents. Acta Physiol. Scand. 67, 373–386 (1966e)
Andén, N.-E., Jukes, M.G.M., Lundberg, A., Vyklicky, L.: The effect of DOPA on the spinal cord. 3. Depolarization evoked in the central terminals of ipsilateral la afferents by volleys in the flexor reflex afferents. Acta Physiol. Scand. 68, 322–336 (1966)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Eur. J. Pharmacol. 2, 59–64 (1967a)
Andén, N.-E., Fuxe, K., Hökfelt, T.: Effect of some drugs on central monamine nerve terminals lacking nerve impulse flow. Eur. J. Pharmacol. 7, 226–232 (1967b)
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967 c)
Andén, N.-E., Butcher, S.G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 77, 303–314 (1970a)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by Clonidine. Life Sci. 9, 513–523 (1970b)
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Eur. J. Pharmacol. 15, 193–199 (1971)
Andén, N.-E., Corrodi, H., Fuxe, K.: Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamine-β-hydroxylase inhibitors. J. Pharm. Pharmacol. 24, 177–182 (1972a)
Andén, N.-E., Engel, J., Rubenson, A.: Mode of action of L-Dopa on central noradrenaline mechanisms. Naunyn Schmiedebergs Arch. Pharmacol. 273, 1–10 (1972b)
Anderson, E.G., Holgerson, L.O.: Distribution of 5-hydroxytryptamine and norepinephrine in cat spinal cord. J. Neurochem. 13, 479–485 (1966)
Anderson, E.G., Haas, H., Hösli, L.: Comparison of effects of noradrenaline and histamine with cyclic AMP on brain stem neurons. Brain Res. 49, 471–475 (1973)
Angrist, B., Sathanathan, G., Wilk, S., Gershon, S.: Amphetamine psychosis: behavioral and biochemical aspects. J. Psychiatr. Res. 11, 13–23 (1974)
Anlezark, G.M., Meldrum, B.S.: Effects of apomorphine, ergocornine and piribedil on audiogenic Scizures in DBA/2 mice. Br. J. Pharmacol. 53, 419–421 (1975)
Anlezark, G., Pycock, C., Meldrum, B.: Ergot alkaloids as dopamine agonists: comparison in two rodent models. Eur. J. Pharmacol. 37, 295–302 (1976)
Anton, A.H., Sayre, D.F.: The distribution of dopamine and dopa in various animals and a method for their determination in diverse biological material. J. Pharmacol. Exp. Ther. 145, 326–336 (1964)
Arvidsson, J., Roos, B.-E., Steg, G.: Reciprocal effects on α- and γ-motoneurones of drugs influencing monoaminergic and cholinergic transmission. Acta Physiol. Scand. 67, 398–404 (1966)
Arvidsson, J., Jurna, L, Steg, G.: Striatal and spinal lesions eliminating reserpine and physo-stigmine rigidity. Life Sci. 6, 2017–2020 (1967)
Atweh, S., Kuhar, M.J.: Autoradiographic localization of opiate receptors in rat brain. III. The telencephalon. Brain Res. 134, 393–405 (1977)
Avanzino, G.L., Bradley, P.B., Comis, S.D., Wolstencroft, J.H.: A comparison of the actions of ergothioneine and chlorpromazine applied to single neurons by two different methods. Neuropharmacology 5, 331–332 (1966)
Axelrod, J., Whitby, L.G., Hertting, G.: Effect of psychotropic drugs on the uptake of H3-nor-epinephrine by tissues. Science 133, 383–384 (1961)
Axelrod, J., Hertting, G., Potter, L.: Effect of drugs on the uptake and release of 3H-norepinephrine in the rat heart. Nature 194, 297 (1962)
Baker, R.G., Anderson, E.G.: The effect of L-3,4, dihydroxyphenylalanine on spinal activity. Pharmacologist 7, 142 (1965)
Baker, R.G., Anderson, E.G.: The effects of L-3,4-dihydroxyphenylalanine on spinal activity. J. Pharmacol. Exp. Ther. 173, 212–223 (1970a)
Baker, R.G., Anderson, E.G.: The antagonism of the effects of L-3,4-dihydroxyphenylalanine on spinal reflexes by adrenergic blocking agents. J. Pharmacol. Exp. Ther. 173, 224–231 (1970 b)
Baraban, J.M., Wang, R.Y., Aghajanian, G.K.: Reserpine suppression of dorsal raphe neuronal firing: mediation by adrenergic system. Eur. J. Pharmacol. 52, 27–36 (1978)
Barasi, S., Roberts, M.H.T.: Responses of motoneurones to electrophoretically applied dopamine. Br. J. Pharmacol. 60, 29–34 (1977)
Barbeau, A.: The pathogenesis of Parkinson’s disease: a new hypothesis. Can. Med. Assc. J. 87, 802–807 (1962)
Barbeau, A., Sourkes, T.L.: Some biochemical aspects of extrapyramidal diseases. Rev. Can. Biol. 20, 197–203 (1961)
Bartholini, G.: Differential effect of neuroleptic drugs on dopamine turnover in the extrapyramidal and limbic system. J. Pharm. Pharmacol. 28, 429–433 (1976)
Bartholini, G., Pletscher, A.: Atropine-induced changes of cerebral dopamine turnover. Experi-entia 27, 1302–1303 (1971)
Bartholini, G., Stadler, H.: Evidence for an intrastriatal GABA-ergic influence on dopamine neurones of the cat. Neuropharmacology 16, 343–347 (1977)
Baruk, H., Launay, J., Berges, J.: Action des drogues psychotropes sur le comportement psychomoteur animal. In: Psychotropic Drugs. S. Garattini and V. Ghetti, Eds., pp. 160–168, Elsevier Publishing Company, Amsterdam (1957)
Bass, A.: Über eine Wirkung des Adrenalins auf das Gehirn. Z. ges. Neurol. Psychiat. 26, 600–601 (1914)
Beaulnes, A., Viens, G.: Catatonie et catalepsie. Rev. Can. Biol. 20, 215–220 (1961)
Bein, H.J.: Zur Pharmakologie des Reserpin, eines neuen Alkaloides, aus Rauwolfia serpentina Benth. Experientia 9, 107–110 (1953)
Ben-Jonathan, N., Oliver, C., Weiner, H.J., Mical, R.S., Porter, J.C.: Dopamine in hypophysial portal plasma of the rat during the estrous cycle and throughout pregnancy. Endocrinology (Phil.) 100, 452–458 (1977)
Berger, P.A.: Medical treatment of mental illness. Science 200, 974–981 (1978)
Bernhard, C.G., Skoglund, C.R.: Potential changes in spinal cord following intra-arterial administration of adrenaline and noradrenaline as compared with acetylcholine effects. Acta Physiol. Scand. 29, suppl. 106, 435–454 (1953)
Bernhard, C.G., Skoglund, C.R., Therman, P.O.: Studies on the potential level in the ventral root under varying condition. Acta Physiol. Scand. 14, suppl. 47. pp. 1–10 (1947)
Bernhard, C.G., Gray, J.A.B., Widén, L.: The difference in response of monosynaptic extensor and monosynaptic flexor reflexes to d-tubocurarine and adrenaline. Acta Physiol. Scand. 29, suppl. 106, 73–78 (1952)
Bertler, Ä, Rosengren, E.: Occurence and distribution of dopamine in brain and other tissues. Experientia 75, 10–11 (1959)
Bertler, Å, Carlsson, A., Rosengren, E.: Release by reserpine of catecholamines from rabbit’s hearts. Naturwissenschaften 43, 521 (1956)
Bertler, Å, Carlsson, A., Lindqvist, M., Magnusson, T.: On the catecholamine levels in blood plasma after stimulation of the sympathoadrenal system. Experientia 14, 184–185 (1958)
Berzewski, H., Helmchen, H., Hippius, H., Hoffmann, H., Kanowski, S.: Das klinische Wirkungsspektrum eines neuen Dibenzodiazepin-Derivates. Arzneim. Forsch. 19, 495–498 (1969)
Besson, M J., Chéramy, A., Feltz, P., Glowinski, J.: Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat. Brain Res. 32, 407–424 (1971)
Besson, M.J., Chéramy, Glowinski, J.: Effects of some psychotropic drugs on dopamine synthesis in the rat striatum. J. Pharmacol. Exp. Ther. 177, 196–205 (1971)
Biegler, D., Giles, S.A., Hockman, C.H.: Dopaminergic influences on swallowing. Neuropharmacology. 16, 245–252 (1977)
Birge, C.A., Jacobs, L.S., Hammer, CT., Daughaday, W.H.: Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. Endocrinology 86, 120–130 (1970)
Biscoe, T.J., Curtis, D.R.: Noradrenaline and inhibition of Renshaw cells. Science 151, 1230 – 1231 (1966)
Biscoe, T.J., Straughan, D.W.: Micro-electrophoretic studies of neurones in the cat hippocampus. J. Physiol. (Lond.) 183, 341–359 (1966)
Biscoe, T.J., Curtis, D.R., Ryall, R.W.: An investigation of catecholamine receptors of spinal interneurones. Neuropharmacology 5, 429–434 (1966)
Bloom, F.E.: Minireview. To spritz or not to spritz: the doubtful value of aimless iontophoresis. Life Sci. 14, 1819–1834(1974)
Bloom, F.E.: The role of cyclic nucleotides in central synaptic functions. Rev. Physiol. Bio-chem. Pharmacol. 74, 1–103 (1975)
Bloom, F.E., Costa, E., Oliver, A.P., Salmoiraghi, G.C.: Caudate nucleus neurons: their responsiveness to iontophoretically administered amines and the effects of anesthetic agents. Fed. Proc. 23, 249 (1964)
Bloom, F.E., Costa, E., Salmoiraghi, G.C.: Anesthesia and the responsiveness of individual neurons of the caudate nucleus of the cat to acetylcholine, norepinephrine and dopamine administered by microelectrophoresis. J. Pharmacol. Exp. Ther. 150, 244–252 (1965)
Bogdanksi, D.F., Weissbach, H., Udenfriend, S.: The distribution of serotonin, 5-hydroxytryp-tamine decarboxylase and monoamine oxidase in brain. J. Neurochem. 1, 272–278 (1957)
Boggan, W.O., Sciden, L.S.: Dopa reversal of reserpine enhancement of audiogenic Scizure susceptibility in mice. Physiol. Behav. 6, 215–217 (1971)
Bonvallet, M., Dell, P., Hiebel, G.: Tonus sympathique et activité électrique corticale. Electro-encephalogr. Clin. Neurophysiol. 6, 119–144 (1954)
Bonvallet, M., Hugelin, A., Dell, P.: Milieu intérieur et activité automatique des cellules réticu-laires mésencéphaliques. J. Physiol. (Paris) 48, 403–406 (1956)
Borison, H.L.: Role of gastrointestinal innervation in digitalis emesis. J. Pharmacol. Exp. Ther. 104, 396–403 (1952)
Borison, H.L.: Area postrema: chemoreceptor trigger zone for vomiting — is that all? Life Sci. 14, 1807–1817 (1974)
Borison, H.L., Brizzee, K.R.: Morphology of emetic chemoreceptor trigger zone in cat medulla oblongata. Proc. Soc. Exp. Biol. Med. 77, 38–42 (1951)
Borison, H.L., Wang, S.C.: Physiology and pharmacology of vomiting. Pharmacol. Rev. 5, 193 (1953)
Boyd, E.M., Cassell, W.A., Boyd, C.E.: Prevention of apomorphine-induced vomiting by (di-methylamino-l-n-propyl-3)-N-(2-chloro)-phenothiazine hydrochloride. Fed. Proc. 12, 303 (1953)
Bradley, P.B.: Microelectrode approach to the neuropharmacology of the reticular formation. In: Psychotropic Drugs. S. Garattini and V. Ghetti, Eds., pp. 207–216. Elsevier Publishing Company, Amsterdam (1957)
Bradley, P.B.: Electrophysiological evidence relating to the role of adrenaline in the central nervous system. Ciba Foundation Symposium on “Adrenergic Mechanisms”, pp. 410–420. Churchill Ltd., London (1960)
Bradley, P.B., Elkes, J.: The effects of some drugs on the electrical activity of the brain. Brain 50,77–117(1957)
Bradley, P.B., Hance, A.J.: The effect of chlorpromazine and methopromazine on the electrical activity of the brain in the cat. Electroencephalogr. Clin. Neurophysiol. 9, 191–215 (1957)
Bradley, P.B., Key, B.J.: The effect of drugs on arousal responses produced by electrical stimulation of the reticular formation of the brain. Electroencephalogr. Clin. Neurophysiol. 10, 97–110(1958)
Bradley, P.B., Mollica, A.: The effect of adrenaline and acetylcholine on single unit activity in the reticular formation of the decerebrate cat. Arch. Ital. Biol. 96, 168–186 (1958)
Bradley, P.B., Wolstencroft, J.H.: Excitation and inhibition of brain stem neurons by noradrenaline and acetylcholine. Nature 196, 840 and 873 (1962)
Bradley, P.B., Wolstencroft, J.H.: Actions of drugs on single neurones in the brain stem. Br. Med. Bull. 21, 15–18 (1965)
Bradley, P.B., Wolstencroft, J.H., Hösli, L., Avanzino, G.L.: Neuronal basis for the central action of chlorpromazine. Nature 212, 1425–1427 (1966)
Brand, E.D., Harris, T.D., Borison, H.L., Goodman, L.S.: The anti-emetic activity of 10-(γ-dimethylamino propyl)-2-chlorophenothiazine (chlorpromazine) in dog and cat. J. Pharmacol. Exp. Ther. 110, 86–92 (1954)
Brodie, B.B., Shore, P.A., Silver, S.L., Pulver, R.: Potentiating action of chlorpromazine and reserpine. Nature 175, 1133–1134 (1955)
Brodie, B.B., Sulser, F., Costa, E.: Theories on mechanism of action of psychotherapeutic drugs. Rev. Can. Biol. 20, 279–285 (1961)
Buchwald, N.A., Price, D.D., Vernon, L., Hull, C.D: Caudate intracellular response to thalamic and cortical inputs. Exp. Neurol. 38, 311–323 (1973)
Bunney, B.S., Aghajanian, G.K.: Electrophysiological effects of amphetamine on dopaminergic neurons. In: Frontiers in Catecholamine Research, S.H. Snyder, E. Usdin, Eds., pp. 957–962, Pergamon Press, Oxford (1973)
Bunney, B.S., Aghajanian, G.K.: A comparison of the effects of chlorpromazine, 7-hy-droxychlorpromazine and chlorpromazine sulfoxide on the activity of central dopaminergic neurons. Life Sci. 15, 309–318 (1974)
Bunney, B.S., Aghajanian, G.K.: d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway. Science 192, 391–393 (1976)
Bunney, B.S., Aghajanian, G.K., Roth, R.H.: Comparison of effect of L-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nature New Biol. 245, 123–125 (1973a)
Bunney, B.S., Walters, J.R., Roth, R.H., Aghajanian, G.K.: Dopaminergic neurones: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185, 560–571 (1973 b)
Burt, D.R., Creese, I., Snyder, S.H.: Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes. Mol. Pharmacol. 12, 800–812 (1976)
Butcher, S.G., Butcher, L.L.: Origin and modulation of acetylcholine activity in the neostriatum. Brain Res. 71, 167–171 (1974)
Butcher, L.L., Talbot, K., Bilizikjian, L.: Acetylcholinesterase neurones in dopamine-contain-ing regions of the brain. J. Neural. Transm. 37, 127–153 (1975)
Calne, D.B.: Developments in the treatment of Parkinsonism. New Engl. J. Med. 295, 1433–1434 (1976)
Capon, A.: Analyse de l’effect d’éveil exercé par l’adrénaline et la noradrénaline et d’autres amines sympathomimétiques sur l’électrocorticogramme du lapin non narcotisé. Arch. Int. Pharmacodyn. Ther. 127, 141–162 (1960)
Carenzi, A., Gillin, J.C., Guidotti, A., Schwartz, M.A., Trabucchi, M., Wyatt, R.J.: Dopamine-sensitive adenyl cyclase in human caudate nucleus. A study in control subjects and schizophrenic patients. Arch. Gen. Psychiatry 32, 1056–1059 (1975)
Carlsson, A.: The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol. Rev. 11, 490–493 (1959)
Carlsson, A.: Discussion. In: Ciba Foundation Symposium on “Adrenergic Mechanisms”, p. 551, J.R. Vane, W. Wolstenholme, M. O’Connor Eds., Little, Brown & Co., Boston (1960)
Carlsson, A.: Evidence for a role of dopamine in extrapyramidal functions. Acta Neuroveget. 26, 484–493 (1964)
Carlsson, A.: Drugs which block the storage of 5-hydroxytryptamine and related amines. In: Handbook of Experimental Pharmacology. Vol. 19: 5-Hydroxytryptamine and Related In-dolealkylamines, O. Eichler and A. Farah, Eds., pp. 529–592, Springer-Verlag, Berlin (1965)
Carlsson, A.: Pharmacological depletion of catecholamine stores. Pharmacol. Rev. 18, 541–549 (1966)
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine and haloperidol on the formation of 3-methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. Toxicol. (Kbh.) 20, 140–144 (1963)
Carlsson, A., Waldeck, B.: Inhibition of 3H-metaraminol uptake by antidepressive and related agents. J. Pharm. Pharmacol. 17, 243–244 (1965)
Carlsson, A., Lindqvist, M., Magnusson, T.: 3,4-Dihydroxyphenylalanine and 5-hydroxytryp-tophan as reserpine antagonists. Nature 180, 1200 (1957a)
Carlsson, A., Rosengren, E., Bertler, Â, Nilsson, J.: Effect of reserpine on the metabolism of catechol amines. In: Psychotropic Drugs. S. Garattini, V. Ghetti, Eds., pp. 363–372, Elsevier Publishing Company, Amsterdam (1957b)
Carlsson, A., Lindqvist, M., Magnusson, T., Waldeck, B.: On the presence of 3-hydroxytyra-mine in brain. Science 127, 471 (1958)
Carlsson, A., Falck, B., Hillarp, N.-Â.: Cellular localization of brain monoamines. Acta Physiol. Scand. 56, suppl. 196: 1–28 (1962)
Carlsson, A., Magnusson, T., Rosengren, E.: 5-Hydroxytryptamine of the spinal cord normally and after transection. Experientia 19, 359 (1963)
Carlsson, A., Falck, B., Fuxe, K., Hillarp, N.-A.: Cellular localization of monoamines in the spinal cord. Acta Physiol. Scand. 60, 112–119 (1964)
Carlsson, A., Kehr, W., Lindqvist, M., Magnusson, T., Atack, C.V.: Regulation of monoamine metabolism in the central nervous system. Pharmacol. Rev. 24, 371–384 (1972)
Caron, M.G., Raymond, V., Lefkowitz, R.J., Labrie, F.: Dopaminergic receptors in the anterior pituitary gland, correlation of [3H]-dihydroergocryptine binding with the dopaminergic control of prolactin release. J. Biol. Chem. 253, 2244–2253 (1978)
Cassell, W.A., Boyd, C.E.: Prevention of apomorphine-induced vomiting by (dimethylamino-l-n-propyl-3)-N-(2-chloro)-phenothiazine hydrochloride. Fed. Proc. 12, 303 (1953)
Cathala, H.P., Pocidalo, J.J.: Sur les effets de l’injection dans les ventricules cérébraux du chien du chlorhydrate de diméthylaminopropyl-N-chloro-phénothiazine (4560 RP). Action centrale de ce produit. C. R. Soc. Biol. (Paris) 146, 1709–1711 (1952)
Chen, G., Ensor, C.R.: Antagonism studies on reserpine and certain CNS depressants. Proc. Soc. Exp. Biol. Med. 87, 602–608 (1954)
Chen, G., Ensor, C.R., Bohner, B.: A facilitation action of reserpine on the central nervous system. Proc. Soc. Exp. Biol. Med. 86, 507–510 (1954)
Chin, J.H., Smith, C.M.: Effects of some central nervous system depressants on the phasic and tonic stretch reflex. J. Pharmacol. Exp. Ther. 136, 276–283 (1962)
Chiueh, C.C., Moore, K.E.: Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-am-phetamine. Brain Res. 50, 221–225 (1973)
Chiueh, C.C., Moore, K.E.: Effects of α-methyltyrosine on d-amphetamine-induced release of endogenously synthesized and exogenously administered catecholamines from the cat brain in vivo. J. Pharmacol. Exp. Ther. 190, 100–108 (1974)
Clement-Cormier, Y.C., Kebabian, J.W., Petzold, G.L., Greengard, P.: Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. Proc. Natl. Acad. Sci. USA 71, 1113–1117 (1974)
Clouet, D.H.: Narcotic Drugs: Biochemical Pharmacology. Plenum Press, New York (1971)
Clubley, M., Elliott, R.C.: Centrally active drugs and the sympathetic nervous system of rabbits and cats. Neuropharmacology 16, 609–616 (1977)
Commissiong, J.W., Sedgwick, E.M.: A pharmacological study of the adrenergic mechanisms involved in the stretch reflex of the decerebrate rat. Br. J. Pharmacol. 50, 365–374 (1974)
Commissiong, J.W., Sedgwick, E.M.: Dopamine and noradrenaline in human spinal cord. Lancet I 347 (1975)
Commissiong, J.W., Gentleman, S., Neff, N.H.: Spinal cord dopaminergic neurons: evidence for an uncrossed nigrospinal pathway. Neuropharmacology 18, 565–568 (1979)
Connor, J.D.: Caudate unit responses to nigral stimuli: evidence for a possible nigro-neostriatal pathway. Science 160, 899–900 (1968)
Connor, J.D.: Caudate nucleus neurones: correlation of the effects of substantia nigra stimulation with iontophoretic dopamine. J. Physiol. (Lond.) 208, 691–703 (1970)
Cools, A.R.: The function of dopamine and its antagonism in the caudate nucleus of cats in relation to the stereotyped behaviour. Arch. Int. Pharmacodyn. Ther. 194, 259–269 (1971)
Cools, A.R.: Chemical and electrical stimulation of the caudate nucleus in freely moving cats: the role of dopamine. Brain Res. 58, 437–451 (1973)
Cools, A., Van Rossum, J.M.: Excitation-mediating and inhibition-mediating dopamine-recep-tors: a new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data. Psychopharmacology (Berlin) 45, 243–254 (1976)
Cools, A.R., Struyker Boudier, H.A.J., Van Rossum, J.M.: Dopamine receptors: relective agonists and antagonists of functionally distinct types within the feline brain. Eur. J. Pharmacol. 37, 283–293 (1976)
Cordeau, J.P., Moreau, A., Beaulnes, A., Laurin, C.: EEG and behavioural changes following microinjection of acetylcholine in the brain stem of cats. Arch. Ital. Biol. 101, 30–47 (1963)
Corrodi, H., Fuxe, K., Hökfelt, T.: The effect of neuroleptics on the activity of central catecholamine neurones. Life Sci. 6, 761–714(1967)
Corrodi, H., Fuxe, K., Hökfelt, T., Lidbrink, P., Ungerstedt, U.: Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons. J. Pharm. Pharmacol. 25, 409–412 (1973)
Costa, E.: Effects of hallucinogenic and tranquilizing drugs on serotonin evoked uterine contractions. Proc. Soc. Exp. Biol. Med. 91, 39–41 (1956)
Costa, E., Gessa, G.L., Hirsch, C., Kuntzman, R., Brodie, B.B.: On current status of serotonin as a brain neurohormone and on action of reserpine-like drugs. Ann. N. Y. Acad. Sci. 96, 118–130(1962)
Costall, B., Naylor, R.J.: Specific asymmetric behaviour induced by the direct chemical stimulation of neostriatal dopaminergic mechanisms. Naunyn Schmiedebergs Arch. Pharmacol. 285, 83–98 (1974a)
Costall, B., Naylor, R.J.: Mesolimbic involvement with behavioural effects indicating antipsychotic activity. Eur. J. Pharmacol. 27, 46–58 (1974b)
Costall, B., Naylor, R.J.: The importance of the ascending dopaminergic systems to the extrapyramidal and mesolimbic brain areas for the cataleptic action of the neuroleptic and cholinergic agents. Neuropharmacology 13, 353–364 (1974c)
Costall, B., Olley, J.E.: Cholinergic- and neuroleptic-induced catalepsy: Modification by lesions in the caudate-putamen. Neuropharmacology 10, 297–306 (1971a)
Costall, B., Olley, J.E.: Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra. Neuropharmacology 10, 581–594 (1971b)
Costall, B., Naylor, R.J., Olley, J.E.: Catalepsy and circling behavior after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain. Neuropharmacology 11, 645–663 (1972)
Courvoisier, S., Fournel, J., Ducrot, R., Kolsky, M., Koetschet, P.: Propriétés pharmacodyna-miques du chlorhydrate de chloro-3 (diméthylamino-3’-propyl)-10 phénothiazine (4.560 R.P.). Etude expérimentale d’un nouveau corps utilisé dans l’anesthésie potentialisé et dans l’hibernation artificielle. Arch. Int. Pharmacodyn. Ther. 92, 305–361 (1953)
Courvoisier, S., Ducrot, R., Mou, L.: Nouveaux aspects expérimentaux de l’activité centrale des dérivés de la phénothiazine. In: Psychotropic Drugs. S. Garattini, V. Ghetti, Eds., pp. 373–391, Elsevier Publishing Company, Amsterdam (1957)
Cranmer, J.I., Brann, A.W., Bach, L.M.N.: An adrenergic basis for bulbar inhibition. Am. J. Physiol. 197, 835–838 (1959)
Creese, I., Snyder, S.H.: Nigrostriatal lesions enhance striated 3H-apomorphine and 3H-spiroperidol binding. Eur. J. Pharmacol. 56, 277–281 (1979)
Creese, I.N.R., Burt, D.R., Snyder, S.H.: Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 129, 481–483 (1976)
Creese, I., Schneider, R., Snyder, S.H.: 3H-spiroperidol labels dopamine receptors in pituitary and brain. Eur. J. Pharmacol. 46, 377–381 (1977)
Crossman, A.R., Walker, R.J., Woodruff, G.N.: Picrotoxin antagonism of γ-aminobutyric acid inhibitory responses and synaptic inhibition in the rat substantia nigra. Br. J. Pharmacol. 49, 696–698 (1973)
Crossman, A.R., Walker, R.J., Woodruff, G.N.: Problems associated with iontophoretic studies in the caudate nucleus and substantia nigra. Neuropharmacology 13, 547–552 (1974)
Crow, T.J.: What is wrong with dopaminergic transmission in schizophrenia? Trends Neurosci. 2, 52–55 (1979)
Curtis, D.R.: The action of 3-hydroxytyramine and some tryptamine derivatives upon spinal neurones. Nature 194, 292 (1962)
Curtis, D.R., Phillis, J.W., Watkins, J.C.: Cholinergic and non-cholinergic transmission in the mammalian spinal cord. J. Physiol. (Lond.) 158, 296–323 (1961)
Dafny, N., Brown, M., Burks, T.F., Rigor, B.M.: Morphine tolerance and dependence: sensitivity of caudate nucleus neurons. Brain Res. 162, 363–368 (1979)
Dahlström, A., Fuxe, K.: Experimentally induced changes in the intraneuronal amine levels of bulbospinal neurone systems. Acta Physiol. Scand. 64, suppl. 247: 1–36 (1965a)
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the central nervous system. Acta Physiol. Scand. 62, suppl. 232 (1965 b)
Dahlström, A., Fuxe, K., Kernell, D., Sedvall, G.: Reduction of the monoamine stores in the terminals of bulbospinal neurones following stimulation in the medulla oblongata. Life Sci. 4, 1207–1212 (1965)
Da Prada, M., Pletscher, A.: On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J. Pharm. Pharmacol. 18, 628–630 (1966 a)
Da Prada, M., Pletscher, A.: Acceleration of the cerebral dopamine turnover by chlor-promazine. Experientia 22, 465–466 (1966 b)
Dasgupta, S.R., Werner, G.: Inhibitory action of chlorpromazine on motor activity. Arch. Int. Pharmacodyn. Ther. 100, 409–417 (1955)
Dasgupta, S.R., Mukherjee, K.L., Werner, G.: The activity of some central depressant drugs in acute decorticate and diencephalic preparations. Arch. Int. Pharmacodyn. Ther. 97, 149 – 156 (1954)
Dell, P.: Intervention of an adrenergic mechanism during brain stem reticular activation. In: Ciba Foundation Symposium (General Series) on “Adrenergic Mechanisms”, pp. 393–409, G.E.W. Wolstenholme, Maeve O’Connor., Eds., Churchill, London (1961)
De Maio, D.: Clozapine, a novel major tranquilizer. Arzneim. Forsch. 22, 919–923 (1972)
Dengler, HJ., Spiegel, H.E., Titus, E.O.: Effects of drugs on uptake of isotopic norepinephrine by cat tissues. Nature 191, 816–817 (1961)
De Robertis, E., Arnaiz, G., Alberici, M., Butcher, R., Sutherland, E.: Subcellular distribution of adenyl cyclase and cyclic phosphodiesterase in rat brain cortex. J. Biol. Chem. 242, 3487 – 3493 (1967)
De Schaepdryver, A.F., Piette, Y., De Launois, A.L.: Brain amines and electroshock threshold. Arch. Int. Pharmacodyn. Ther. 140, 358–367 (1962)
Dettmar, P.W., Cowan, A., Walter, D.S.: Naloxone antagonizes behavioural effects of d-am-phetamine in mice and rats. Neuropharmacology 17, 1041–1044 (1978)
De Wied, D.: Chlorpromazine and endocrine function. Pharmacol. Rev. 19, 251–288 (1967)
Dunstan, R., Jackson, D.M.: The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long term treatment with halo-peridol. Psychopharmacology (Berlin) 48, 105–114 (1976)
Ellaway, P.H., Pascoe, J.E.: Blockage of a spinal pathway by chlorpromazine. J. Physiol. (Lond.) 183, 46–47 P (1966)
Ellaway, P.H., Pascoe, J.E.: Noradrenaline as a transmitter in the spinal cord. J. Physiol. (Lond.) 197, 8–10 P (1968)
Ellaway, P.H., Trott, J.R.: The mode of action of 5-hydroxytryptophan in facilitating a stretch reflex in the spinal cat. Exp. Brain Res. 22, 145–162 (1975)
Engberg, I., Marshall, K.C.: Mechanism of noradrenaline hyperpolarization in spinal cord mo-toneurones of the cat. Acta Physiol. Scand. 83, 142–144 (1971)
Engberg, I., Marshall, K.C.: Reversal potential for noradrenaline-induced hyperpolarization of spinal motoneurones of cats. J. Gen. Physiol. 61, 261 (1973)
Engberg, I., Ryall, R.W.: The action of mono-amines upon spinal neurones. Life Sci. 4, 2223–2227 (1965)
Engberg, I., Ryall, R.W.: The inhibitory action of noradrenaline and other monoamines on spinal neurones. J. Physiol. (Lond.) 185, 298–322 (1966)
Engberg, I., Thaller, A.: Hyperpolarizing actions of noradrenaline in spinal motoneurones. Acta Physiol. Scand. 80, 34A–35A (1970)
Engberg, I., Lundberg, A., Ryall, R.W.: Is the tonic decerebrate inhibition of reflex paths mediated by monoaminergic pathways? Acta Physiol. Scand. 72, 123–133 (1968)
Engberg, I., Flatman, J.A., Kadzielawa, K.: The hyperpolarization of motoneurones by elec-trophoretically applied amines and other agents. Acta Physiol. Scand. 91, 3 A–4A (1974)
Ernst, A.M.: Relation between the action of dopamine and apomorphine and their O-methyl-ated derivatives upon the CNS. Psychopharmacologia 7, 391–399 (1967)
Esplin, D.W., Heaton, D.G.: Effects of reserpine on spinal cord synaptic transmission. J. Pharmacol. Exp. Ther. 121, 267–271 (1955)
Fedina, L., Lundberg, A., Vyklicky, L.: The effect of a noradrenaline liberator (4,alpha-di-methyl-meta-tyramine) on reflex transmission in spinal cats. Acta Physiol. Scand. 83,495–504 (1971)
Feldberg, W., Sherwood, S.L.: Injections of drugs into the lateral ventricle of the cat. J. Physiol. (Lond.) 123, 148–167 (1954)
Fellows, E.J., Cook, L.: The comparative pharmacology of a number of phenothiazine derivatives. In: Psychotropic Drugs. S. Garattini, V. Ghetti, Eds., pp. 397–404, Elsevier Publishing Company, Amsterdam (1957)
Feltz, P.: Dopamine, aminoacids and caudate unitary responses to nigral stimulation. J. Physiol. (Lond.) 205, 8–9 P (1969)
Feltz, P.: Relation nigro-striatale: essai de differentiation des excitations et inhibitions par micro-iontophorèse de dopamine. J. Physiol. (Paris) 62,151 (1970)
Feltz, P.: Monoamines and the excitatory nigro-striatal linkage. Experientia 27, 1111–1112 (1971a)
Feltz, P.: Sensitivity to haloperidol of caudate neurones excited by nigral stimulation. Eur. J. Pharmacol. 14, 360–364 (1971b)
Feltz, P.: γ-Aminobutyric acid and a caudato-nigral inhibition. Can. J. Physiol. Pharmacol. 49, 1113–1115 (1971c)
Feltz, P., Albe-Fessard, D.: A study of an ascending nigrocaudate pathway. Electroence-phalogr. Clin. Neurophysiol. 33, 179–193 (1972)
Feltz, P., De Champlain, J.: Persistence of caudate unitary responses to nigral stimulation after destruction and functional impairment of the striatal dopaminergic terminals. Brain Res. 43, 595–600 (1972 a)
Feltz, P., De Champlain, J.: Enhanced sensitivity of caudate neurons to microiontophoretic injections of dopamine in 6-hydroxydopamine treated rats. Brain Res. 43, 601–605 (1972 b)
Feltz, P., Mackenzie, J.S.: Properties of caudate unitary responses to repetitive nigral stimulation. Brain Res. 13, 612–616 (1969)
Flach, F.: Clinical effectiveness of reserpine. Ann. N. Y. Acad. Sci. 61, 161–166 (1955)
Flückiger, E., Wagner, H.R.: 2-Br-α-Ergokryptin: Beeinflussung von Fertilität und Laktation bei der Ratte. Experientia 24, 1130–1131 (1968)
Fonnum, F., Grofová, I, Rinvik, E., Storm-Mathisen, J., Walberg, F.: Origin and distribution of glutamine decarboxylase in the substantia nigra of the cat. Brain Res. 71, 77–92 (1974)
Forssberg, H., Grillner, S.: The locomotion of the acute spinal cat injected with Clonidine i.v. Brain Res. 50, 184–186 (1973)
Frantz, A.G.: Catecholamines and the control of prolactin secretion in humans. Prog. Brain Res. 39, 311–322(1973)
Frigyesi, T.L., Purpura, D.P.: Electro-physiological analysis of reciprocal caudato-nigral relations. Brain Res. 6, 440–456 (1967)
Fu, T.-C., Jankowska, E., Lundberg, A.: Reciprocal Ia inhibition during the late reflexes evoked from the flexor reflex afferents after DOPA. Brain Res. 85, 99–102 (1975)
Fuxe, K., Gunne, L.-M.: Depletion of the amine stores in brain catecholamine terminals on amygdaloid stimulation. Acta Physiol. Scand. 62, 493–494 (1964)
Fuxe, K., Hökfelt, T., Johansson, O., Jonsson, G., Lidbrink, P., Ljungdahl, Å: The origin of the dopamine nerve terminals in limbic and frontal cortex. Evidence for meso-cortico dopamine neurons. Brain Res. 82, 349–355 (1974)
Gaddum, J.H., Vogt, M.: Some central actions of 5-hydroxytryptamine and various antagonists. Br. J. Pharmacol. 11, 175–179 (1956)
Gaitondé, B.B., McCarthy, L.E., Borison, H.L.: Central emetic action and toxic effects of digitalis in cats. J. Pharmacol. Exp. Ther. 147, 409–415 (1965)
Gale, K., Moroni, F., Kumakura, K., Guidotti, A.: Opiate-receptors in substantia nigra: role in the regulation of striatal tyrosine hydroxylase activity. Neuropharmacology 18, 427–430 (1979)
Gangloff, H., Monnier, M.: Topische Bestimmung des zerebralen Angriffs von Reserpin (Ser-pasil). Experientia 11, 404–407 (1955)
Geffen, L.B., Jessell, T.M., Cuello, A.C., Iversen, L.L.: Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258–260 (1976)
Gérardy, J., Quinaux, N., Maeda, T., Dresse, A.: Analyse des monoamines du locus coeruleus et d’autres structures cérébrales par Chromatographie sur couche mince. Arch. Int. Pharma-codyn. Ther. 177, 492–496 (1969)
Gey, K.F., Pletscher, A.: Effects of chlorpromazine on the metabolism of dl-2-C14-Dopa in the rat. J. Pharmacol. Exp. Ther. 145, 337–343 (1964)
Glaviano, V.V., Wang, S.C.: Dual mechanism of anti-emetic action of 10 (γ-dimethylaminopro-pyl)-2-chlorphenothiazine hydrochloride (chlorpromazine) in dogs. J. Pharmacol. Exp. Ther. 114, 358–366 (1955)
Glow, P.: Some aspects of the effects of acute reserpine treatment on behaviour. J. Neurol. Neurosurg. Psychiatry 22, 11–32 (1959)
Glowinski, J., Axelrod, J.: Effect of drugs on the uptake, release, and metabolism of H3-nor-epinephrine in the rat brain. J. Pharmacol. Exp. Ther. 149, 43–49 (1965)
Glowinski, J., Axelrod, J.: Effects of drugs on the disposition of 3H-norepinephrine in the rat brain. Pharmacol. Rev. 18, 775–785 (1966)
Glowinski, J., Iversen, L.L.: Regional studies of catecholamines in the rat brain. I. The disposition of [3H] norepinephrine, [3H] dopamine and [3H] dopa in various regions of the brain. J. Neurochem. 13, 655–669 (1966)
Gokhale, S.D., Gulati, O.D., Parikh, H.M.: An investigation of the adrenergic blocking action of chlorpromazine. Br. J. Pharmacol. 23, 508–520 (1964)
Goldstein, M., Anagnoste, B., Owen, W.S., Battista, A.F.: The effects of ventromedial segmental lesions on the disposition of dopamine in the caudate nucleus of the monkey. Brain Res. 4, 298–300 (1967)
Goldstein, M., Anagnoste, B., Shirron, C.: The effect of trivastal, haloperidol and dibutyryl cyclic AMP on [14C] dopamine synthesis in rat striatum. J. Pharm. Pharmacol. 25, 348–351 (1973)
Goldstein, M., Lieberman, A., Battista, A.F., Lew, J.Y., Matsumoto, Y.: Experimental and clinical studies on bromocriptine in the Parkinsonism syndrome. Acta Endocrinol. (Co-penh.) 88, suppl. 216, 57–66 (1978)
Gonzalez-Vegas, J.A.: Antagonism of dopamine-mediated inhibition in the nigro-striatal pathway: a mode of action of some catatonia-inducing drugs. Brain Res. 80, 219–228 (1974)
Graham, A.W., Aghajanian, G.K.: Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature 234, 100–102 (1971)
Granit, R.: Receptors and Sensory Perception. Yale University Press, New Haven (1955)
Griffith, J.D., Cavanaugh, J., Held, J., Oates, J.A.: Dextroamphetamine, evaluation of psy-chomimetic properties in man. Arch. Gen. Psychiatry 26, 97–100 (1972)
Grillner, S.: The influence of DOPA on the static and the dynamic fusimotor activity to the triceps surae of the spinal cat. Acta Physiol. Scand. 77, 490–509 (1969)
Grillner, S.: Locomotion in the spinal cat. In: Control of Posture and Locomotion. R.B. Stein, K.B. Pearson, R.S. Smith, and J.B. Redford, Eds., pp. 515–535, Plenum Press, New York (1973)
Gross, H., Langner, E.: Das Wirkungsprofil eines chemisch neuartigen Breitbandneurolepti-kums der Dibenzodiazepingruppe. Wien. Med. Wochenschr. 116, 814–816 (1966)
Grossmann, W., Jurna, I., Nell, T.: The effect of reserpine and DOPA on reflex activity in the rat spinal cord. Exp. Brain Res. 22, 351–361 (1975)
Grossmann, W., Jurna, I., Nell, T., Theres, C.: The dependence of the anti-nociceptive effect of morphine and other analgesic agents on spinal motor activity after central monoamine depletion. Eur. J. Pharmacol. 24, 67–77 (1973)
Groves, P.M., Rebec, G.V., Harvey, J.A.: Alteration of the effects of (+)-amphetamine on neuronal activity in the striatum following lesions of the nigrostriatal bundle. Neuropharmacology 14, 369–376 (1975 a)
Groves, P.M., Wilson, C.J., Young, S.J., Rebec, G.V.: Self-inhibition by dopaminergic neurons. An alternative to the “neuronal feedback loop” hypothesis for the mode of action of certain psychotropic drugs. Science 190, 522–529 (1975 b)
Gulley, R.L., Smithberg, M.: Synapses in the rat substantia nigra. Tissue Cell 3, 691–700 (1971)
Guyenet, P.G., Agid, Y., Javoy, F., Beaujouan, J.C., Rossier, J., Glowinsky, J.: Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system. Brain Res. 84, 227–244 (1975 a)
Guyenet, P.G., Javoy, F., Agid, Y., Beaujouan, J.C., Glowinski, J.: Dopamine receptors and cholinergic neurons in the rat neostriatum. Adv. Neurol. 943–51 (1975 b)
Gyermek, L.: Chlorpromazine: a serotonin antagonist? Lancet II: 724 (1955)
Häggendal, J., Hamberger, B.: Quantitative in vitro studies on noradrenaline uptake and its inhibition by amphetamine, desipramine and chlorpromazine. Acta Physiol. Scand. 70, 277–280 (1967)
Hamberger, B.: Reserpine-resistant uptake of catecholamines in isolated tissues of the rat. Acta Physiol. Scand. 71, 1–56 (1967)
Harris, J.E.: Beta adrenergic receptor-mediated adenosine cyclic 3′,5′-monophosphate accumulation in the rat corpus striatum. Mol. Pharmacol. 12, 546–558 (1976)
Harris, J.E., Baldessarini, R., Wheeler, S.: Stimulation of tyrosine hydroxylation in striatal syn-aptosomes by derivatives of adenosine 3′,5′-cyclic phosphate. Fed. Proc. 33, 521 (1974a)
Harris, J.E., Morgenroth III, V.H., Roth, R.H., Baldessarini, R.J.: Regulation of catecholamine synthesis in the rat brain in vitro by cyclic AMP. Nature 252, 156–158 (1974 b)
Heal, D.J., Phillips, A.G., Green, A.R.: Studies on the locomotor activity produced by injection of dibutyryl cyclic 3′5′AMP into the nucleus accumbens of rats. Neuropharmacology 17, 265–270 (1978)
Heinz, G., Jurna, I.: The anti-nociceptive effect of reserpine and haloperidol mediated by the nigro-striatal system: antagonism by naloxone. Naunyn Schmiedebergs Arch. Pharmacol. 306, 97–100 (1979)
Henatsch, H.D., Ingvar, D.H.: Chlorpromazin und Spastizität: Eine experimentelle elektrophy-siologische Untersuchung. Arch. Psychiatr. Z. Neurol. 195, 77–93 (1956)
Herman, E.H., Barnes, C.D.: Evidence for an action of chlorpromazine on the spinal cord. Fed. Proc. 23, 456 (1964)
Hernández-Peôn, R.: Central neuro-humoral transmission in sleep and wakefulness. In: Sleep Mechanisms. Progress in Brain Research, Vol. 18, pp. 96–117. Akert, K., Bally, C., Schadé, J.P., Eds., Elsevier Publishing Company, Amsterdam (1963)
Hertting, G., Axelrod, J., Whitby, L.G.: Effect of drugs on the uptake and metabolism of H3-norepinephrine. J. Pharmacol. Exp. Ther. 134, 146–153 (1961)
Herz, A., Gogolák, G.: Mikroelektrophoretische Untersuchungen am Septum des Kaninchens. Pflügers Arch. 285, 317–330 (1965)
Herz, A., Nacimiento, A.: Über die Wirkung von Pharmaka auf Neurone des Hippocampus nach mikroelektrophoretischer Verabfolgung. Naunyn Schmiedebergs Arch. Pharmacol. 257,295–314(1965)
Herz, A., Von Freytag-Loringhoven, H.: Über die synaptische Erregung im Corpus striatum und deren antagonistische Beeinflussung durch mikroelektrophoretisch verabfolgte Glutaminsäure und Gamma-Aminobuttersäure. Pflügers Arch. Ges. Physiol. 229, 167–184 (1968)
Herz, A., Zieglgänsberger, W.: Synaptic excitation in the corpus striatum inhibited by microelectrophoretically administered dopamine. Experientia 22, 839–840 (1966)
Herz, A., Zieglgänsberger, W.: The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum. Neuropharmacology 7, 221–230 (1968)
Hiebel, G., Bonvallet, M., Dell, P.: Action de la chlorpromazine (“Largactil”, 4560 RP) au niveau du système nerveux central. Hop. Paris 30, 2346–2353 (1954)
Hillarp, N.- Å., Fuxe, K., Dahlström, A.: Demonstration and mapping of central neurons containing dopamine, noradrenaline, and 5-hydroxytryptamine and their reactions to psycho-pharmaca. Pharmacol. Rev. 18, 121–141(1966)
Hilton, S.M., Zbrozyna, A.W.: Amygdaloid region for defence reactions and its efferent pathway to the brain stem. J. Physiol. (Lond.) 165, 160–173 (1963)
Hoffer, B.J., Siggins, G.R., Bloom, F.E.: Cyclic 3′,5′-adenosine monophosphate (c-AMP) mediation of the response of rat cerebellar Purkinje cells to norepinephrine (NE): Blockade with prostaglandins. Pharmacologist 11, 238 (1969)
Hofmann, M., Battaini, F., Tonon, G., Trabucchi, M. Spano, P.: Interaction of sulpiride and ergot derivatives on rat brain DOPAC concentration and prolactin secretion in vivo. Eur. J. Pharmacol. 56, 15–20 (1979)
Hong, J.S., Yang, H.-Y.T., Costa, E.: On the location of methionine enkephalin neurons in rat striatum. Neuropharmacology 16, 451–453 (1977)
Horn, A.S., Snyder, S.H.: Chlorpromazine and dopamine: conformational similarities that correlate with the antischizophrenic activity of phenothiazine drugs. Proc. Natl. Acad. Sci. USA 68, 2325–2328 (1971)
Hornykiewicz, O.: Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev. 18, 925–964 (1966)
Huang, M., Ho, A.K.S., Daly, J.W.: Accumulation of adenosine cyclic 3′,5′-monophosphate in rat cerebral cortical slices. Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5-trihydroxyphenethylamine and dihydroxytryp-tamines. Mol. Pharmacol. 9, 711–717 (1973)
Hudson, R.D.: Effects of chlorpromazine on spinal cord reflex mechanisms. Neuropharmacology 5, 43–58 (1966)
Hudson, R.D., Domino, E.F.: Effects of chlorpromazine on some motor reflexes. Neuropharmacology 2, 143–162 (1963)
Hudson, R.D., Domino, E.F.: Comparative effects of three substituted phenothiazines on the patellar reflex and mean arterial blood pressure of the rabbit. Arch. Int. Pharmacodyn. Ther. 147, 36–42 (1964)
Huidobro, F.: Some pharmacological properties of chloro-3(dimethylamine-3′ propyl)10-phe-nothiazine or 4.560 R. P. Arch. Int. Pharmacodyn. Ther. 98, 308–319 (1954)
Hull, C.D., Bernardi, G., Buchwald, N.A.: Intracellular responses of caudate neurons to brain stem stimulation. Brain Res. 22, 163–179 (1970)
Hull, C.D., Bernardi, G., Price, D.D., Buchwald, N.A.: Intracellular responses of caudate neurons to temporaly and spatially combined stimuli. Exp. Neurol. 38, 324–336 (1973)
Hyttel, J.: Effects of neuroleptics on 3H-haloperidol and 3H-cis(Z)-flupenthixol binding and on adenylate cyclase activity in vitro. Life Sci. 23, 551–556 (1978)
Irwin, S., Houde, R.W., Bennet, D.R., Hendershot, L.C., Seevers, M.H.: The effects of morphine, methadone and meperidine on some reflex responses in spinal animals to nociceptive stimulation. J. Pharmacol. Exp. Ther. 101, 132–143 (1951)
Iversen, L.L.: The inhibition of noradrenaline uptake by drugs. In: Advances in Drug Research. Harper, N.J., Simmonds, A.B., Eds., 2, 1–46, Academic Press, London (1965)
Iversen, L.L.: Dopamine receptors in the brain (A dopamine-sensitive adenylate cyclase models synaptic receptors, illuminating antipsychotic drug action). Science 188, 1084–1089 (1975)
Iversen, L.L.: More than one type of dopamine receptor in brain? Trends Neuro Sci. 1, V–VI (1978 a)
Iversen, L.L.: Biochemical and pharmacological studies: the dopamine hypothesis. In: Schizophrenia: Towards a New Synthesis. J. K. Wing, Ed., Academic Press, London, pp. 89–116 (1978 b)
Ivy, A.C., Goetzel, F.R., Harris, S.C., Burril, D.Y.: The analgesic effect of intracarotid and intravenous injection of epinephrine in dogs and of subcutaneous injection in man. Quart. Bull. Northwestern University Med. School 18, 298–306 (1944)
Iwamoto, E., Way, L.: Circling behaviour and stereotypy induced by intranigral opiate microinjections. J. Pharmacol. Exp. Ther. 203, 347–359 (1977)
Iwatsubo, K., Clouet, D.H.: Dopamine-sensitive adenylate cyclase of the caudate nucleus of rats treated with morphine or haloperidol. Biochem. Pharmacol. 24, 1499–1503 (1975)
Iwatsubo, K., Clouet, D.H.: Effects of morphine and haloperidol on the electrical activity of rat nigrostriatal neurons. J. Pharmacol. Exp. Ther. 202, 429–436 (1977)
Jacobowitz, D.M., Goldberg, A.M.: Determination of acetylcholine in discrete regions of the rat brain. Brain Res. 122, 575–577 (1971)
James, T.A., Massey, S.: Evidence for a possible dopaminergic link in the action of acetylcholine in the rat substantia nigra. Neuropharmacology 17, 687–690 (1978)
Jankowska, E., Jukes, M.G.M., Lund, S., Lundberg, A.: Reciprocal innervation through inter-neuronal inhibition. Nature 206, 198–199 (1965)
Jankowska, E., Jukes, M.G.M., Lund, S., Lundberg, A.: The effect of dopa on the spinal cord. 5. Reciprocal organization of pathways transmitting excitatory action to alpha-mo-toneurones of flexors and extensors. Acta Physiol. Scand. 70, 369–388 (1967 a)
Jankowska, E., Jukes, M.G.M., Lund, S., Lundberg, A.: The effect of DOPA on the spinal cord. 6. Halfcentre organization of interneurones transmitting effects from the flexor reflex afferents. Acta Physiol. Scand. 70, 389–402 (1967 b)
Janssen, P.A.J.: The pharmacology of haloperidol. Int. J. Neuropsychiatr. 3, suppl. 1, S 10—S 18 (1967)
Janssen, P.A.J., Allewijn, F.T.N.: The distribution of the butyrophenones haloperidol, trifluperidol, moperone, and clofluperidol in rats, and its relationship with their neuroleptic activity. Arzneim. Forsch. 19, 199–208 (1969)
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part I: “Neuroleptic activity spectra” for rats. Arzneim. Forsch. 15, 104–117 (1965 a)
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part II: “Neuroleptic activity spectra” for dogs. Arzneim. Forsch. 15, 1196–1206 (1965 b)
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L., Dresse, A., Lenaerts, F.M., Pinchard, A., Schaper, W.K.A., Van Nueten, J.M., Verbruggen, F.J.: Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. Part I: The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Arzneim. Forsch. 18, 261–279 (1968a)
Janssen, P.A.J., Soudijn, W., Van Wijngaarden, L, Dresse, A.: Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. Part III: Regional distribution of pimozide and haloperidol in the dog brain. Arzneim. Forsch. 18, 282–287 (1968 b)
Javoy, P., Agid, Y., Bouvet, D., Glowinski, J.: Changes in neostriatal DA metabolism after car-bachol or atropine microinjections into the substantia nigra. Brain Res. 68, 253–260 (1974)
Jenney, E.H.: Changes in convulsant thresholds after Rauwolfia serpentina, reserpine and veriloid. Fed. Proc. 13, 370–371 (1954)
Jobe, P.C., Geiger, P.F., Ray, T.B., Woods, T.W., Mims, M.E.: The relative significance of spinal cord norepinephrine and 5-hydroxytryptamine in electrically induced Scizure in the rat. Neuropharmacology 77, 185–190 (1978)
Johnson, A.M., Loew, D.M., Vigouret, J.M.: Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Br. J. Pharmacol. 56, 59–68 (1976)
Johnstone, E.C., Crow, T.J., Frith, C.D., Carney, M.W.P., Price, J.S.: Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet I: 848–851 (1978)
Jordan, L.M., Lake, N., Phillis, J.W.: Mechanism of noradrenaline depression of cortical neurones: a species comparison. Eur. J. Pharmacol. 20, 381–384 (1972)
Juorio, A.V., Sharman, D.F., Trajkov, T.: The effect of drugs on the homovanillic acid content of the corpus striatum of some rodents. Br. J. Pharmacol. 26, 385–392 (1966)
Jurna, L: Dämpfung repetivier Aktivierungsvorgänge an der spinalen Motorik durch Morphin. In: Schmerz (Pain). R. Janzen, W.D. Keidel, A. Herz, C. Steichele, J.P. Payne and R.A.P. Burt, Eds., pp. 267–269. Stuttgart: Thieme 1972
Jurna, I.: Striatal monoamines and reserpine and chlorpromazine rigidity. Pharmacol. Ther. [B] 2, 113–128 (1976a)
Jurna, I.: The cholinergic rigidity. Pharmacol. Ther. [B] 2, 413–421 (1976b)
Jurna, I., Heinz, G.: Anti-nociceptive effect of morphine, opioid analgesics and haloperidol injected into the caudate nucleus of the rat. Naunyn Schmiedebergs Arch. Pharmacol. 309, 145–151 (1979)
Jurna, L, Lanzer, G.: Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidity. Naunyn Schmiedebergs Arch. Pharmacol. 262, 309–324 (1969)
Jurna, I., Lundberg, A.: The influence of an inhibitor of dopamine-beta-hydroxylase on the effect of DOPA on transmission in the spinal cord. In: Structure and Functions of Inhibitory Neuronal Mechanisms, pp. 215–219, C. von Euler, S. Skoglund, U. Söderberg, Eds., Pergamon Press, Oxford, New York (1968)
Jurna, L, Regélhy, B.: The antagonism between reserpine some antiparkinson drugs in elec-troScizure. Naunyn Schmiedebergs Arch. Pharmacol. 259, 442–459 (1968)
Jurna, I., Theres, C.: The effect of phenytoin and metamphetamine on spinal motor activity. Naunyn Schmiedebergs Arch. Pharmacol. 265, 244–259 (1969)
Jurna, I., Theres, C., Bachmann, T.: The effect of physostigmine and tetrabenazine on spinal motor control and its inhibition by drugs which influence reserpine rigidity. Naunyn Schmiedebergs Arch. Pharmacol. 263, 427–438 (1969)
Jurna, I., Nell, T., Schreyer, L: Motor disturbance induced by tremorine and oxotremorine. Naunyn Schmiedebergs Arch. Pharmacol. 267, 80–98 (1970)
Jurna, I., Grossmann, W., Nell, T.: Depression by amantadine of drug-induced rigidity in the rat. Neuropharmacology 11, 559–564 (1972a)
Jurna, I., Ruzdic, N., Nell, T., Grossmann, W.: The effect of α-methyl-p-tyrosine and substantia nigra lesions on spinal motor activity in the rat. Eur. J. Pharmacol. 20, 341–350 (1972b)
Jurna, I., Grossmann, W., Theres, C.: Inhibition by morphine of repetitive activation of cat spinal motoneurons. Neuropharmacology 12, 983–993 (1973)
Jurna, I., Brenner, M., Drum, P.: Abolition of spinal motor disturbance by injections of dopamine receptor agonists, atropine and GABA into the caudate nucleus. Neuropharmacology 77, 35–44 (1978a)
Jurna, I., Heinz, G., Blinn, G., Nell, T.: The effect of substantia nigra stimulation and morphine on α-motoneurones and the tail-flick response. Eur. J. Pharmacol. 51, 239–250 (1978 b)
Kaelber, W.W., Joynt, R.J.: Tremor production in cats given chlorpromazine. Proc. Soc. Exp. Biol. Med. 92, 399–402 (1956)
Kalisker, A., Rutledge, C.O., Perkins, J.P.: Effect of nerve degeneration by 6-hydroxydopamine on chatecholamine-stimulated adenosine 3′,5′-monophosphate formation in rat cerebral cortex. Mol. Pharmacol. 9, 619–629 (1973)
Kamberi, I.A., Mical, L.S., Porter, J.C.: Effect of anterior pituitary perfusion and intraventricular injection of catecholamines and indolamines in LH release. Endocrinology 87, 1–12 (1970)
Karobath, M., Leitich, H.: Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain. Proc. Natl. Acad. Sci. USA 77, 2915–2918 (1974)
Kebabian, J.W.: Multiple classes of dopamine receptors in mammalian central nervous system: the involvement of dopamine-sensitive adenyl cyclase. Life Sci. 23, 479–484 (1978)
Kebabian, J.W., Calne, D.B.: Multiple receptors for dopamine. Nature 277, 93–96 (1979)
Kebabian, J.W., Greengard, P.: Dopamine-sensitive adenyl cyclase: possible role in synaptic transmission. Science 174, 1346–1349 (1971)
Kebabian, J.W., Saavedra, J.M.: Dopamine-sensitive adenylate cyclase occurs in a region of substantia nigra containing dopaminergic dendrites. Science 193, 683–685 (1976)
Kebabian, J.W., Petzold, G.L., Greengard, P.: Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the dopamine receptor. Proc. Natl. Acad. Sci. USA 69, 2145–2149 (1972)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972)
Kelly, P.H., Miller, R.J.: The interaction of neuroleptic and muscarinic agents with central dopaminergic system. Br. J. Pharmacol. 54, 115–121 (1975)
Kelly, P.H., Moore, K.E.: Mesolimbic dopaminergic neurones in the rotational model of nigro-striatal function. Nature 263, 695–696 (1976)
Kelly, P.H., Moore, K.E.: Dopamine concentrations in the rat brain following injections into the substantia nigra of baclofen, γ-aminobutyric acid, y-hydroxybutyric acid, apomorphine and amphetamine. Neuropharmacology 17, 169–174 (1978)
Kety, S.S., Javoy, F., Thierry, A.-M., Julou, L., Glowinski, J.: A sustained effect of electroconvulsive shock on the turnover of norepinephrine in the central nervous system of the rat. Proc. Natl. Acad. Sci. USA 58, 1249–1254 (1967)
Key, B.J.: Electrocortical changes induced by perfusion of catecholamines into the brainstem reticular formation. Neuropharmacology 14, 41–51 (1975)
Killam, E.K., Killam, K.F.: A comparison of the effects of reserpine and chlorpromazine to those of barbiturates on central afferent systems in the cat. J. Pharmacol. Exp. Ther. 116, 35 (1956)
Killam, E.K., Killam, K.F., Shaw, T.: The effects of psychotherapeutic compounds on central afferent and limbic pathways. Ann. N. Y. Acad. Sci. 66, 784–805 (1957)
Kim, J.-S., Hassler, R.: Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra. Brain Res. 88, 150–153 (1975)
Kim, J.S., Bak, I.J., Hassler, R., Okada, Y.: Role of γ-aminobutyric acid (GABA) in the extrapyramidal motor system. 2. Some evidence for the existence of a type of GABA-rich strio-nigral neurons. Brain Res. 14, 95–104 (1971)
King, J.L.: The cortico-spinal tract of the rat. Anat. Rec. 4, 245–252 (1910)
Kinross-Wright, V.: Chlorpromazine and reserpine in the treatment of psychoses. Ann. N.Y. Acad. Sci. 61, 174–182 (1955)
Kitai, S.T., Wagner, A., Precht, W., Ohno, T.: Nigro-caudate and caudato-nigral relationship: an electrophysiological study. Brain Res. 85, 44–48 (1975)
Kitai, S.T., Sugimori, M., Kocsis, J.D.: Excitatory nature of dopamine in the nigro-caudate pathway. Exp. Brain Res. 24, 351–363 (1976)
Klawans, H.L.: The pharmacology of Parkinsonism (a review). Dis. Nerv. Syst. 29, 805–817 (1968)
Klawans, H.L., Rubovits, R.: An experimental model of tardive dykinesia. J. Neural. Transm. 33, 235–246 (1972)
Kleinberg, D.L., Noel, G.L., Frantz, A.G.: Chlorpromazine stimulation and L-DOPA suppression of plasma prolactin in man. J. Clin. Endocrinol. Metab. 33, 873–876 (1971)
Kline, N.S., Stanley, A.M.: Use of reserpine in a neuropsychiatrie hospital. Ann. N. Y. Acad. Sci. 61, 85–91 (1955)
Kobinger, W.: Reversibility of a facilitatory action of reserpine on the central nervous system, by methylamphetamine. Experientia 14, 337–338 (1958)
Koe, B.K., Weissman, A.: p-chlorophenylalanine: a specific depletor of brain serotonin. J. Pharmacol. Exp. Ther. 154, 499–516 (1966)
Kolmodin, G.M., Skoglund, C.R.: Properties and functional differentiation of interneurons in the ventral horn of the cat’s lumbar cord as revealed by intracellular recording. Experientia 10, 505–506 (1954)
Korf, J., Zieleman, M., Westerink, B.H.C.: Dopamine release in substantia nigra. Nature 260, 257–258 (1976)
Kosterlitz, H.W., Collier, H.O.J., Villareal, J.E.: Agonist and Antagonist Actions of Narcotic Analgesic Drugs. Macmillan, London (1972)
Kreindler, A., Steriade, M., Zuckermann, E., Chimon, D.: The influence of chlorpromazine upon cerebello-cortical and cerebellospinal circuits. Electroencephalogr. Clin. Neuro-physiol. 10, 515–520 (1958)
Krnjevic, K., Phillis, J.W.: Actions of certain amines on cerebral cortical neurones. Br. J. Pharmacol. 20, 471–490 (1963)
Kruglov, N.A., Sinitsyn, L.N.: The effect of aminozine and mepazine on the cerebellar and bulbar inhibitory mechanisms. Farmak. Toksikol. 22, 97–101 (1959)
Kuschinsky, K., Hornykiewicz, O.: Morphine catalepsy in the rat: relation to striatal dopamine metabolism. Eur. J. Pharmacol. 19, 119–122 (1972)
Laborit, H., Huguenard, P.: L’hibernation artificielle par moyens pharmacodynamiques et physiques. Presse Med. 59, 1329 (1951)
Ladinsky, H., Consolo, S., Bianchi, S., Samanin, R., Ghezzi, D.: Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine. Brain Res. 84, 221–226 (1975)
Lake, N., Jordan, L.M.: Failure to confirm cyclic AMP as second messenger for norepinephrine in rat cerebellum. Science 183, 663–664 (1974)
Lake, N., Jordan, L.M., Phillis, J.W.: Mechanisms of noradrenaline action in cat cerebral cortex. Nature New Biol. 240, 249–250 (1972)
Lake, N., Jordan, L.M., Phillis, J.W.: Evidence against cyclic adenosine 3′,5′-monophosphate (cAMP) mediation of noradrenaline depression of cerebral cortical neurones. Brain Res. (60,411–421 (1973)
Launay, J. Despature, M.: Syndromes psycho-moteurs et syndromes extra-pyramidaux au cours de traitements prolongés par la chlorpromazine. Ann. Med. Psychol. (Paris) 114, 340–344 (1956)
Laverty, R., Sharman, D.F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenyl-ethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Br. J. Pharmacol. 24, 759–772 (1965)
Legge, K.F., Randic, M., Straughan, D.W.: The pharmacology of neurones in the pyriform cortex. Br. J. Pharmacol. 26, 87–107 (1966)
Lee, C.-Y., Akera, T., Stolman, S., Brody, T.M.: Saturable binding of dihydromorphine and naloxon to rat brain tissue in vitro. J. Pharmacol. Exp. Ther. 194, 583–592 (1975)
Lee, C.M., Wong, P.C.L., Chan, S.H.H.: The involvement of dopaminergic neurotransmission in the inhibitory effect of morphine on caudate neurone activities. Neuropharmacology 16, 571–576 (1977)
Lee, T., Seeman, P., Tourtelotte, W.W., Farley, I.J., Hornykiewicz, O.: Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains. Nature 274, 897–900 (1978)
Lee, H.K., Chai, C.Y., Chung, P.M., Wang, S.C.: Central antiemetic actions of pimozide and haloperidol in the dog. Neuropharmacology 18, 341–346 (1979)
Lehmann, A.: Contribution à l’étude psycho-physiologique et neuropharmacologique de l’épi-lepsie acoustique de la souris et du rat. II. Etude expérimentale. Agressologie 5, 311–351 (1964)
Lehmann, A.: Audiogenic Scizures data in mice supporting new theories of biogenic amines mechanisms in the central nervous system. Life Sci. 6, 1423–1431 (1967)
Leimdorfer, A.: Über zentrale Wirkungen von Adrenalin. Wien. Klin. Wochenschr. 60, 382 – 385 (1948)
Leimdorfer, A.: The action of sympathomimetic amines on the central nervous system and the blood sugar. Mechanism of action. J. Pharmacol. Exp. Ther. 98, 62–71 (1950)
Leimdorfer, A., Metzner, W.R.T.: Analgesia and anaesthesia induced by epinephrine. Am. J. Physiol. 157, 116–121 (1949)
Leonard, B.E.: Drug-induced changes in brain tyrosine hydroxylase activity in vivo. Neuropharmacology 16, 41–52(1977)
Levin, R.M., Weiss, B.: Mechanism by which psychotropic drugs inhibit adenosine cyclic 3′,5′-monophosphate phosphodiesterase of brain. Mol. Pharmacol. 12, 581–589 (1976)
Leysen, J., Laduron, P.: Differential distribution of opiate and neuroleptic receptors and the dopamine sensitive adenylate cyclase in rat brain. Life Sci. 20, 281–288 (1972)
Lindvall, O., Björklund, A.: The organization of the ascending catecholamine neurone system in the rat brain as revealed by glyoxylic acid fluorescence method. Acta Physiol. Scand. [Suppl.] 412, 1–48 (1974)
Lindvall, O., Björklund, A., Moore, R.Y., Stenevi, U.: Mesencephalic dopamine neurons projecting to neocortex. Brain Res. 81, 325–331 (1974)
Linowiecki, A.J.: The comparative anatomy of the pyramidal tract. J. Comp. Neurol. 24, 509–530 (1914)
Loizou, L.A.: Projections of the nucleus coeruleus in the albino rat. Brain Res. 15, 563–560 (1969)
Longo, V.G., Silvestrini, B.: Effect of adrenergic and cholinergic drugs injected by intracarotid route on electrical activity of brain. Proc. Soc. Exp. Biol. Med. 95, 43–41(1957)
Longo, V.G., von Berger, G.P., Bovet, D.: Action of nicotine and of the “ganglioplégiques centraux” on the electrical activity of the brain. J. Pharmacol. Exp. Ther. 111, 349–359 (1954)
Lu, K.-H., Amenomori, Y., Chen, C.-L., Meites, J.: Effects of central acting drugs on serum and pituitary prolactin levels in rats. Endocrinology (Philadelphia) 87, 667–672 (1970)
Lundberg, A.: Monoamines and spinal reflexes. In: Studies in Physiology. D.R. Curtis and A.K. Mclntyre, Eds., pp. 186–190, Springer-Verlag, Berlin (1965)
Lynch, G.S., Lucas, PA., Deadwyler, S.A.: The demonstration of acetylcholinesterase-contain-ing neurones within the caudate nucleus of the rat. Brain Res. 45, 617–621 (1972)
MacLeod, R.M.: Regulation of prolactin secretion. In: Frontiers in Neuroendocrinology, Vol. 4. L. Martini, W.F. Ganong, Eds., New York, Raven Press, pp. 169–194 (1976)
MacLeod, R.M., Fontham, E.H., Lehmeyer, J.E.: Prolactin and growth hormone production as influenced by catecholamines. Neuroendocrinology 6, 283–294 (1970)
Magnusson, T.: Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryp-tamine in the rat spinal cord. Naunyn Schmiedebergs Arch. Pharmacol. 278, 13–22 (1973)
Magnusson, T., Rosengren, E.: Catecholamines of the spinal cord normally and after transection. Experientia 19, 229–230 (1963)
Maler, L., Fibiger, H.C., McGeer, P.L.: Demonstration of the nigro striatal projection by silver staining after nigral injection of 6-hydroxydopamine. Exp. Neurol. 40, 505–515 (1973)
Malhotra, C.L., Sidhu, R.K.: The anti-emetic activity of alkaloids of Rauwolfia serpentina. J. Pharmacol. Exp. Ther. 116, 123–129 (1956)
Malmfors, T.: Studies on adrenergic nerves. The use of rat and mouse iris for direct observations on their physiology and pharmacology at cellular and subcellular levels. Acta Physiol. Scand. 64, Suppl. 248, 1–93 (1963)
Mantegazzini, P., Poeck, K., Santibafiez, H.G.: The action of adrenaline and noradrenaline on the cortical electrical activity of the “encéphale isolé” cat. Arch. Ital. Biol. 97, 222–242 (1959)
Marley, E., Vane, J.R.: Tryptamine receptors in the central nervous system. Nature 198, 441–444 (1963)
Marsden, C.D., Milson, J., Parkes, J.D., Pycock, C., Tarsy, D.: The effect of cholinergic and anticholinergic drugs on rotational behavior in mice with destruction of one nigrostriatal pathway. J. Physiol. (Lond.) 249, 64p–65p (1975)
Martin, W.R., Demaar, E.W.J., Unna, K.R.: Chlorpromazine: I. The action of chlorpromazine and related phenothiazines on the EEG and its activation. J. Pharmacol. Exp. Ther. 122, 343–358 (1958)
Martin, W.R., Riehl, J.L., Unna, K.R.: Chlorpromazine. III. The effects of chlorpromazine and chlorpromazine sulfoxide on vascular responses to L-epinephrine and levarterenol. J. Pharmacol. Exp. Ther. 130, 37–45 (1960)
Mason, S.T., Iversen, S.D.: Learning in the absence of forebrain noradrenaline. Nature 258, 422–424 (1975)
Mason, S.T., Iversen, S.D.: Effects of selective forebrain noradrenaline loss on behavioural inhibition in the rat. J. Comp. Physiol. Psychol. 91, 165–173 (1977)
Mason, S.T., Iversen, S.D.: Reward, attention and the dorsal noradrenergic bundle. Brain Res. 150, 135–148 (1978)
Matthysse, S.: Antipsychotic drug actions: A clue to the neuropathology of schizophrenia? Fed. Proc. 32, 200–205 (1973)
Mayer, D.J., Price, D.D.: Central nervous system mechanisms of analgesia. Pain 2, 379–404 (1976)
McAfee, D.A., Greengard, P.: Adenosine 3′,5′-monophosphate: electrophysiological evidence for a role in synaptic transmission. Science 178, 310–312 (1972)
McGeer, E.G., McGeer, P.L.: Catecholamine content of spinal cord. Can. J. Biochem. Physiol. 40, 1141–1151 (1962)
McGeer, E.G., McGeer, P.L., McLennan, H.: The inhibitory action of 3-hydroxytyramine, gamma-aminobutyric acid (GABA) and some other compounds towards the crayfish stretchreceptor neuron. J. Neurochem. 8, 36–49 (1961)
McGeer, E.G., Fibiger, H.C., McGeer, P.L., Brooke, S.: Temporal changes in amine synthesizing enzymes of rat extrapyramidal structures after hemitransection or 6-hydroxydopamine administration. Brain Res. 52, 289–300 (1973)
McGeer, P.L., Fibiger, H.C., Hattori, T., Singh, V.K., McGeer, E.G., Maler, L.: Biochemical neuroanatomy of the basal ganglia. In: Neurohumoral Coding and Brain Function, Advances in Behaviour and Biology 10, 27–48, R.D. Myers, R.R. Drucker-Colin, Eds. (1974a)
McGeer, P.L., Grewaal, D.S., McGeer, E.G.: Influence of noncholinergic drugs on rat striatal acetylcholine levels. Brain Res. 80, 211–217 (1974b)
McGeer, E.G., McGeer, P.L., Grewaal, D.S., Singh, V.K.: Striatal cholinergic interneurons and their relation to dopaminergic nerve endings. J. Pharmacol. (Paris) 6, 143–152 (1975)
McGeer, P.L., McGeer, E.G., Wada, J.A.: Central aromatic amine levels and behavior. II. Serotonin and catecholamine levels in various cat brain areas following administration of psycho-active drugs on amine precursors. Arch. Neurol. 9, 81–89 (1963)
McGillard, K.L., Takemori, A.E.: The effect of dopaminergic modifiers on morphine-induced analgesia and respiratory depression, Eur. J. Pharmacol. 54, 61–68 (1979)
McKenzie, G.M., Sadof, M.: Effects of morphine and chlorpromazine on apomorphine-induced stereotyped behaviour. J. Pharm. Pharmacol. 26, 280–282 (1974)
McLennan, H.: The effect of some catecholamines upon a monosynaptic reflex pathway in the spinal cord. J. Physiol. (Lond.) 158, 411–425 (1961)
McLennan, H., York, D.H.: The action of dopamine on neurons of the caudate nucleus. J. Physiol. (Lond.) 189, 393–402 (1967)
McNair, J.L., Sutin, J., Tsubokawa, T.: Suppression of cell firing in the substantia nigra by caudate nucleus stimulation. Exp. Neurol. 37, 395–411 (1972)
Melville, K.I.: Observations on the adrenergic-blocking and antifibrillatory actions of chlorpromazine. Fed. Proc. 13, 386–387 (1954)
Messing, R.B., Lytle, L.D.: Serotonin-containing neurons: their possible role in pain and analgesia. Pain 4, 1–21 (1977)
Miller, R.J., Iversen, L.L.: Effect of chlorpromazine and some of its metabolites on the dopa-mine-sensitive adenylate cyclase of rat brain striatum. J. Pharm. Pharmacol. 26, 142–144 (1974)
Miller, R.J., Horn, A.S., Iversen, L.L.: The action of neuroleptic drugs on dopamine-stimulated adenosine cyclic 3′,5′-monophosphate production in rat neostriatum and limbic forebrain. Mol. Pharmacol. 10, 759–766 (1974)
Minneman, K.P., Quik, M., Emson, P.C.: Receptor linked cyclic AMP systems in rat neostriatum: differential localization revaled by kainic acid injection. Brain Res. 151, 507–521 (1978)
Moore, R.Y., Bhatnagar, R.K., Heller, A.: Anatomical and chemical studies of a nigro-neostriatal projection in the cat. Brain Res. 30, 119–135 (1971)
Morest, D.K.: A study of the structure of the area postrema with Golgi methods. Am. J. Anat. 107, 291–303 (1960)
Morest, D.K.: Experimental study of the projections of the nucleus of the tractus solatarius and the area postrema in the cat. J. Comp. Neurol. 130, 277–300 (1966)
Morpurgo, C.: Effects of anti-Parkinson drugs on a phenothiazine induced catatonic reaction. Arch. Int. Pharmacodyn. Ther. 137, 84–90 (1962)
Munoz, C., Goldstein, L.: Quantitative EEG studies on the action of adrenergic blocking drugs upon the analeptic effects of DL amphetamine in rabbits. Pharmacologist 2, 80 (1960)
Murrin, L.C., Morgenroth, V.H., Roth, R.H.: Dopaminergic neurons: effects of electrical stimulation on tyrosine hydroxylase. Mol. Pharmacol. 12, 1070–1081 (1976)
Muscholl, E., Vogt, M.: The action of reserpine on sympathetic ganglia. J. Physiol. (Lond.) 136,7 P (1957)
Muscholl, E., Vogt, M.: The action of reserpine on the peripheral sympathetic system. J. Physiol. (Lond.) 141, 132–155 (1958)
Nagy, J.I., Lee, T., Seeman, P., Fibiger, H.C.: Direct evidence for presynaptic and postsynaptic dopamine receptors in brain. Nature 274, 278–281 (1978)
Nathan, P.W.: Pain. Brit. med. Bull. 33, 149–156 (1977)
Ng, K.Y., Chase, T.N., Colburn, R.W., Kopin, I.J.: L-Dopa induced release of cerebral monoamines. Science 170, 76–77 (1970)
Nieoullon, A., Chéramy, A., Glowinski, J.: Release of dopamine in vivo from cat substantia nigra. Nature 266, 375–377 (1977 a)
Nieoullon, A., Cheramy, A., Glowinski, J.: Nigral and striatal dopamine release under sensory stimuli. Nature 269, 340–342 (1977 b)
Nieoullon, A., Cheramy, A., Glowinski, J.: Interdependence of the nigrostriatal dopaminergic systems on the two sides of the brain in the cat. Science 198, 416–418 (1977 c)
Nieoullon, A., Cheramy, A., Leviel, V., Glowinski, J.: Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat. Euro. J. Pharmacol. 53, 289–296 (1979)
Nybäck, H., Sedvall, G.: Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14in brain. J. Pharmacol. Exp. Ther. 162, 294–301 (1968)
Nybäck, H., Sedvall, G.: Effect of nigral lesion on chlorpromazine-induced acceleration of dopamine synthesis from [14C]tyrosine. J. Pharm. Pharmacol. 23, 322–326 (1971)
Nybäck, H., Sedvall, G., Kopin, I.J.: Accelerated synthesis of dopamine-C14from tyrosine-C14in rat brain after chlorpromazine. Life Sci. 6, 2307–2312 (1967)
Nybäck, H., Borzecki, Z., Sedvall, G.: Accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain; effect of some psychotropic drugs. Eur. J. Pharmacol. 4, 395–403 (1968)
Okada, Y., Hassler, R.: Uptake and release of γ-aminobutyric acid (GABA) in slices of substantia nigra of rat. Brain Res. 49, 214–217 (1973)
O’Keeffe, R., Sharman, D.F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Br. J. Pharmacol. 38, 287–304 (1970)
Olpe, H.-R., Koella, W.P.: Inhibition of nigral and neocortical cells by γ-hydroxy butyrate: a microiontophoretic investigation. Eur. J. Pharmacol. 53, 359–364 (1979)
Owen, F., Cross, A.J., Crow, T.J., Longen, A., Poulter, M., Riley, G.J.: Increased dopamine-receptor sensitivity in schizophrenia. Lancet II: 223–226 (1978)
Paalzow, G., Paalzow, L.: Clonidine antinociceptive activity: effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat. Naunyn Schmiedebergs Arch. Pharmacol. 292, 119–126 (1976)
Palmer, G.C.: Increased cyclic AMP response to norepinephrine in the rat brain following 6-hydroxydopamine. Neuropharmacology 11, 145–149 (1972)
Palmer, G.C., Jones, D.J., Medina, M.A., Stavinoha, W.B.: Action of psychoactive drugs on cyclic AMP levels in mouse cerebral cortex and lung following microwave irradiation. Pharmacologist 17, 233 (1975)
Palmer, G.C., Jones, D.J., Medina, M.A., Stavinoha,W.B.: Influence of injected psychoactive drugs on cyclic AMP levels in mouse brain and lung following microwave irradiation. Neuropharmacology 16, 435–443 (1977)
Palmer, G.C., Jones, D.J., Medina, M.A., Palmer, S.J., Stavinoha, W.B.: Actions in vitro and in vivo of chlorpromazine and haloperidol on cyclic nucleotide systems in mouse cerebral cortex and cerebellum. Neuropharmacology 17, 491–498 (1978)
Pepeu, G.: Involvement of central transmitters in narcotic analgesia. In: Advances in Pain Research and Therapy. J.J. Bonica, D. Albe-Fessard, Eds., Vol. 1: 595–600, Raven Press, New York (1976)
Perkins, J.P., Moore, M.M.: Characterization of the adrenergic receptors mediating a rise in cyclic 3′,5′-adenosine monophosphate in rat cerebral cortex. J. Pharmacol. Exp. Ther. 185, 371–378 (1973)
Peroutka, S.J., U’Prichard, D.C., Greenberg, D.A., Snyder, S.H.: Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain. Neuropharmacology 16, 549–556 (1977)
Persson, S.-Å.: Effect of morphine on the accumulation of DOPA after decarboxylase inhibition in the rat. Eur. J. Pharmacol. 55, 121–128 (1979)
Pert, C.B., Snyder, S.H.: Opiate receptor: demonstration in nervous tissue. Science 779, 1011 – 1014 (1973)
Pert, C.B., Kuhar, M.J., Snyder, S.H.: Autoradiographic localization of the opiate receptor in rat brain. Life Sci. 16, 1849–1854 (1975)
Phillis, J.W., Tebēcis, A.K.: The effects of pentobarbitone sodium on acetylcholine excitation and noradrenaline inhibition of thalamic neurones. Life Sci. 6, 1621–1625 (1967 a)
Phillis, J.W., Tebëcis, A.K.: The responses of thalamic neurones to iontophoretically applied monoamines. J. Physiol. (Lond.) 192, 715–745 (1967 b)
Phillis, J.W., York, D.H.: Strychnine block of neural and drug induced inhibition in the cerebral cortex. Nature 216, 922–923 (1967)
Phillis, J.W., Tebëcis, A.K., York, D.H.: Depression of spinal motoneurones by noradrenaline, 5-hydroxytryptamine and histamine. Eur. J. Pharmacol. 4, 471–475 (1968)
Pijnenburg, A.J.J., Van Rossum, J.M.: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmacol. 25, 1003–1005 (1973)
Pijnenburg, A.J.J., Woodruff, G.N., Van Rossum, J.M.: Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens. Brain Res. 59, 289–302 (1973)
Pijnenburg, A.J.J., Honig, W.M.M., Van Rossum, J.M.: Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacology (Berlin) 41, 175–180 (1975)
Pijnenburg, A.J.J., Honig, W.M.M., Struyker Boudier, H.A.J., Cools, A.R., Van der Heyden, J.A.M., Van Rossum, J.M.: Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat. Arch. Int. Phar-macodyn. Ther. 222, 103–115 (1976)
Pocidalo, J.J., Cathala, H.P., Himbert, J.: Action sur l’excitabilité sympathique du chlorhydrate de diméthylaminopropyl-N-chlorophénothiazine (4560 R. P.). C. R. Soc. Biol. (Paris) 146, 368–370 (1952)
Poirier, L.J., Sourkes, I.L.: Influence of the substantia nigra on the catecholamine content of the striatum. Brain 88, 181–192 (1965)
Pollard, H., Llorens, C., Schwartz, J.C., Cross, C., Dray, F.: Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigro striatal dopaminergic system. Brain. Res. 757, 392–398 (1978)
Precht, W., Yoshida, M.: Blockage of caudate-evoked inhibition of neurons in the substantia nigra by picrotoxin. Brain Res. 32, 229–233 (1971)
Preston, J.B.: Chlorpromazine: a possible mechanism of action. Fed. Proc. 15,468–469 (1956 a)
Preston, J.B.: Effects of chlorpromazine on the central nervous system of the cat: A possible neural basis for action. J. Pharmacol. Exp. Ther. 118, 100–115 (1956b)
Pycock, C., Tarsy, D., Marsden, C.D.: Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Psychopharmacology (Berlin) 45, 211–219(1975)
Quastel, D.M.J., Hackett, J.T., Okamoto, K.: Presynaptic action of central depressant drugs: inhibition of depolarization-secretion coupling. Can. J. Physiol. Pharmacol. 50, 279 (1972)
Quik, M., Iversen, L.L.: Regional study of 3H-spiperone binding and the dopamine-sensitive adenylate cyclase in rat brain. Eur. J. Pharmacol. 56, 323–330 (1979)
Quik, M., Iversen, L.L., Larder, A., Mackay, A.U.P.: Use of ADTN to define specific 3H-spiperone binding to receptors in brain. Nature 274, 513–514 (1978)
Randrup, A., Munkvad, I.: Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacology (Berlin) 77, 300–310 (1967)
Ranson, S.W.: The fasciculus cerebro-spinalis in the albino rat. Am. J. Anat. 14, 411–424 (1913)
Ranson, S.W.: A note on the degeneration of the fasciculus cerebro-spinalis in the albino rat. J. Comp. Neurol. 24, 503–507 (1914)
Ritchie, J.M., Greengard, P.: On the active structure of local anesthetics. J. Pharmacol. Exp. Ther. 133, 241–245 (1961)
Roberge, C., Ebstein, B., Goldstein, M.: Stimulation of tyrosine hydroxylase (T.H.) activity by dibutyryl cyclic AMP (dB-cAMP) in synaptosomal preparations (S.P.). Fed. Proc. 33, 521 (1974)
Roberts, M.H.T., Straughan, D.W.: An excitatory effect of 5-hydroxytryptamine on single cerebral cortical neurones. J. Physiol. (Lond.) 188, 27–28 P (1966)
Roos, B.-E.: Effects of certain tranquillisers on the level of homovanillic acid in the corpus striatum. J. Pharm. Pharmacol. 17, 820–821 (1965)
Roos, B.-E., Steg, G.: The effect of L-3,4-dihydroxyphenylalanine and DL-5-hydroxytrypto-phan on rigidity and tremor induced by reserpine, chlorpromazine and phenoxybenzamine. Life Sci. 3, 351–360 (1964)
Rothballer, A.B.: Studies on the adrenaline-sensitive component of the reticular activating system. Electroencephalogr. Clin. Neurophysiol. 8, 603–621 (1956)
Ryall, R.W.: Some actions of chlorpromazine. Br. J. Pharmacol. 11, 339–345 (1956)
Salmoiraghi, G.C., Stefanis, C.N.: Patterns of central neurons responses to suspected transmitters. Arch. Ital. Biol. 103, 705–724 (1965)
Sano, I., Gamo, T., Kakimoto, Y., Taniguchi, K., Takasada, M., Nishinuma, K.: Distribution of catechol compounds in human brain. Biochim. Biophys. Acta 32, 586–587 (1959)
Satoh, H., Satoh, Y., Notsu, Y., Honda, F.: Adenosine 3′,5′-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra. Eur. J. Pharmacol. 39, 365–377 (1976)
Sayers, A.C., Burki, H.R., Ruch, W., Asper, H.: Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine. Psychopharmacology (Berlin) 41, 97–104 (1975)
Schaumann, W.: Beeinflussung der analgetischen Wirkung des Morphins durch Reserpin. Nau-nyn Schmiedebergs Arch. Pharmacol. 235, 1–9 (1958)
Schildkraut, J.J., Kety, S.S.: Biogenic amines and emotion. Science 156, 21–30 (1967)
Schlosser, W., Horst, W.D., Spiegel, H.E., Sigg, E.B.: Apomorphine and its effects on the spinal cord. Neuropharmacology 11, 417–426 (1972)
Schneider, J.A.: Further studies on the central action of reserpine (Serpasil). Am. J. Physiol. 179, 670–671 (1954a)
Schneider, J.A.: Reserpine antagonism of morphine analgesia in mice. Proc. Soc. Exp. Biol. Med. 87, 614–615 (1954b)
Schneider, J.A.: Further characterization of central effects of reserpine (Serpasil). Am. J. Physiol. 181, 64–68 (1955)
Schneider, J.A., Earl, A.E.: Effects of Serpasil on behavior and autonomic regulating mechanisms. Neurology 4, 657–667 (1954)
Schulte, F.J., Henatsch, H.D.: Unterdrückung tonischer Eigenschaften von Alpha- und Gamma-Motoneuronen durch Phenothiazinkörper. Pflügers Arch. Ges. Physiol. 268, 65–66 (1958)
Schultz, J., Daly, J.W.: Accumulation of cyclic adenosine 3′,5′-monophosphate in cerebral cortical slices from rat and mouse: stimulatory effect of a- and β-adrenergic agents and adenosine. J. Neurochem. 21, 1319–1326 (1973)
Schultz, W., Ungerstedt, U.: Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour. Neuropharmacology 17, 349–353 (1978)
Schwarcz, R., Creese, I., Coyle, J.T., Snyder, S.H.: Dopamine receptors localized on cerebral cortical afferents to rat corpus striatum. Nature 277, 766–768 (1978)
Schwartz, J.C., Costentin, L, Martes, M.P., Protais, P., Baudry, M.: Review: modulation of receptor mechanisms in the CNS: hyper- and hyposensitivity to catecholamines. Neuropharmacology 17, 665–685 (1978)
Schweitzer, A., Wright, S.: The action of adrenaline on the knee jerk. J. Physiol. (Lond.) 88, 476–491 (1937)
Seeman, P.M., Bialy, H.S.: The surface activity of tranquilizers. Biochem. Pharmacol. 12, 1181–1191 (1963)
Seeman, P., Lee, T.: Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188, 1217–1219 (1975)
Seeman, P., Lee, T., Chau-Wong, M., Wong, K.: Antipsychotic drug doses and neuroleptic/ dopamine receptors. Nature 261, 717–719 (1976)
Seeman, P., Staiman, A., Chau-Wong, M.: The nerve impulse-blocking actions of tranquilizers and the binding of neuroleptics to synaptosome membranes. J. Pharmacol. Exp. Ther. 190, 123–130 (1974)
Seeman, P., Tedesco, J., Titeler, M., Hartley, E.J.: Antischizophrenic drugs: membrane sites of action. Advan. Pharmacol. Therap. Vol. 5. Neuropsychopharmacol. C. Dumont (Ed.), Oxford: Pergamon Press, pp. 3–20 (1978)
Segal, M., Pickel, V., Bloom, F.: The projections of the nucleus locus coerulus: an autoradiographic study. Life Sci. 13, 817–821 (1973)
Sethy, V.H., Van Woert, M.H.: Effect of L-DOPA on brain acetylcholine and choline in rats. Neuropharmacology 12, 27–31 (1973)
Sethy, V.H., Van Woert, M.H.: Regulation of striatal acetylcholine concentration by dopamine receptors. Nature 251, 529–530 (1974 a)
Sethy, V.H., Van Woert, M.H.: Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists. Res. Commun. Chem. Path. Pharmacol. 8, 13–28 (1974b)
Shaar, C.J., Smalstig, E.B., Clemens, J.A.: The effect of catecholamines, apomorphine, and monoamine oxidase on rat anterior pituitary prolactin release in vitro. Pharmacologist 15, 256 (1973)
Share, N.N., Chai, C.Y., Wang, S.C.: Emesis induced by intra-cerebroventricular injections of apomorphine and deslanoside in normal and chemoreceptive trigger zone ablated dogs. J. Pharmacol. Exp. Ther. 147, 416–421 (1965)
Sharman, D.F.: Changes in the metabolism of 3,4-dihydroxy-phenylethylamine (dopamine) in the striatum of the mouse induced by drugs. Br. J. Pharmacol. 28, 153–163 (1966)
Shore, P.A., Brodie, B.B.: Influence of various drugs on serotonin and norepinephrine in the brain. In: Psychotropic Drugs. S. Garattini, V. Ghetti, Eds., pp. 423–427, Elsevier Publishing Company, Amsterdam (1957)
Shore, P.A., Silver, S.L., Brodie, B.B.: Interaction of reserpine, serotonin and lysergic acid diethylamide in brain. Science 122, 284–285 (1955)
Shore, P.A., Pletscher, A., Tomich, E.G., Carlsson, A., Kuntzman, R., Brodie, B.B.: Role of brain serotonin in reserpine action. Ann. N. Y. Acad. Sci. 66, 609–617 (1957)
Sibley, D.R., Creese, I.: Guanine nucleotides regulate anterior pituitary dopamine receptors. Eur. J. Pharmacol. 55, 341–343 (1979)
Sigg, E.B., Ochs, S., Gerard, R.W.: Effects of medullary hormones on the somatic nervous system in the cat. Am. J. Physiol. 183, 419–426 (1955)
Sigg, E.B., Caprio, G., Schneider, J.A.: Synergism of amines and antagonism of reserpine to morphine analgesia. Proc. Soc. Exp. Biol. Med. 97, 97–100 (1958)
Siggins, G.R., Hoffer, B.J., Bloom, F.E.: Cyclic adenosine monophosphate: possible mediator for norepinephrine effects on cerebellar Purkinje cells. Science 165, 1018–1020 (1969)
Siggins, G.R., Hoffer, B.J., Bloom, F.E.: Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. III. Evidence for mediation of norepinephrine effects by cyclic 3′,5′-adenosine monophosphate. Brain Res. 25, 535–553 (1971a)
Siggins, G.R., Oliver, A.P., Hoffer, B.J., Bloom, F.E.: Cyclic adenosine monophosphate and norepinephrine: Effects of transmembrane properties of cerebellar Purkinje cells. Science 171, 192–194 (1971b)
Siggins, G.R., Battenberg, E.F., Hoffer, B.J., Bloom, F.E., Steiner, A.L.: Noradrenergic stimulation of cyclic adenosine monophosphate in rat Purkinje neurons: an immuno-cytochemi-cal study. Science 179, 585–588 (1973)
Siggins, G.R., Hoffer, B.J., Ungerstedt, U.: Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons. Life Sci. 15, 779–792 (1974)
Sigwald, J., Bouttier, D., Courvoisier, S.: Les accidents neurologiques des médications neuroleptiques. Rev. Neurol. (Paris) 100, 31–73 (1959)
Silvestrini, B., Maffii, G.: Effects of chlorpromazine, promazine, diethazine, reserpine, hydroxyzine, and morphine upon some mono- and polysynaptic motor reflexes. J. Pharm. Pharmacol. 17, 224–233 (1959)
Smalstig, E.B., Sawyer, B.D., Clemens, J.A.: Inhibition of rat prolactin release by apomorphine in vivo and in vitro. Endocrinology 95, 123–129 (1974)
Smith, C.M., Murayama, S.: Rigidity of spinal origin: quantitative evaluation of agents with muscle relaxant activity in cats. Neuropharmacology 3, 505–515 (1964)
Sourkes, T.L.: Formation of dopamine in vivo: relation to the function of the basal ganglia. Rev. Can. Biol. 20, 187–196 (1961)
Stadler, H., Lloyd, K.G., Gadea-Ciria, M., Bartholini, G.: Enhanced striatal acetylcholine release by chlorpromazine and its reversal by apomorphine. Brain Res. 55, 476–480 (1973)
Stefanis, C.: Hippocampal neurons: their responsiveness to micro-electrophoretically administered endogenous amines. Pharmacologist 6, 171 (1964)
Steg, G.: Efferent muscle innervation and rigidity. Acta Physiol. Scand. 61, suppl. 225 (1964)
Steg, G.: Efferent muscle control and rigidity. In: Muscular Afferents and Motor Control. Nobel Symposium I, pp. 437–443, R. Granit, Ed., Almqvist & Wiksell, Stockholm and John Willy & Sons, New York, London, Sydney (1966)
Stern, J., Ward, A.A.: Supraspinal and drug modulation of the α-motor system. A. M. A. Arch. Neurol. 6, 404–413 (1962)
Sternbach, R.A., Janowsky, D.S., Huey, L.Y., Segal, D.S.: Effects of altering brain serotonin activity on human chronic pain. In: Advances in Pain Research and Therapy, Vol. 1 J.E. Bonica, D. Albe-Fessard, Eds., pp. 601–606. New York: Raven Press 1976
Stevens, J.: An anatomy of schizophrenia. Arch. Gen. Psychiaty 29, 177–189 (1973)
Stille, G., Hippius, H.: Kritische Stellungnahme zum Begriff der Neuroleptika (anhand von pharmakologischen und klinischen Befunden mit Clozapin). Pharmakopsychiatr. Neuro-psychopharmakol. 4, 182–191 (1971)
Stille, G., Lauener, H., Eichenberger, E.: The pharmacology of 8-chloro-11-(4-methyl-l-pipe-razinyl)-5H-dibenzo (b,e) (1,4) diazepine (clozapine). Farmaco [Prat.] 26, 603–625 (1971)
Struyker Boudier, H.A.J., Gielen, W., Cools, A.R., Van Rossum, J.M.: Pharmacological analysis of dopamine-induced inhibition and excitation of neurones in the snail Helix aspersa. Arch. Int. Pharmacodyn. Ther. 209, 324–331 (1974)
Svensson, T.H., Bunney, B.S., Aghajanian, G.K.: Inhibition of both noradrenergic and serotonergic neurons in brain by the α-adrenergic agonist Clonidine. Brain Res. 92, 291–306 (1975)
Szabo, J.: Projections from the body of the caudate nucleus in the rhesus monkey. Exp. Neurol. 27, 1–15 (1970)
Szabo, J.: The course and distribution of efferents from the tail of the caudate nucleus in the monkey. Exp. Neurol. 37, 562–572 (1972)
Takaori, S., Fukuda, N., Amano, Y.: Mode of action of chlorpromazine on unit discharges from nuclear structures in the brain stem of cats. Jpn. J. Pharmacol. 20, 424–431 (1970)
Takaori, S., Nakai, Y., Matsuoka, I., Sasa, M., Fukuda, N., Shimamoto, K.: The mechanism of antagonism between apomorphine and metoclopramide on unit discharges from nuclear structures in the brainstem of the cat. Neuropharmacology 7, 115–126 (1968)
Tarsy, D., Baldessarini, R.J.: Pharmacologically induced behavioral supersensitivity to apomorphine. Nature New Biol. 245, 262–263 (1973)
Tedeschi, D.H., Tedeschi, R.E., Fellows, E.J.: The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs. J. Pharm. Exp. Ther. 126, 223–232 (1959)
Ten Cate, J., Boeles, J.T.F., Biersteker, P.A.: The action of adrenaline and noradrenaline on the knee jerk. Arch. Int. Physiol. Biochim. 67, 468–488 (1959)
Thierry, A.M., Blanc, G., Sobel, A., Stinus, L., Glowinski, J.: Dopaminergic terminals in the rat cortex. Science 182, 499–501 (1973)
Titeler, M., Seeman, P.: Antiparkinsonian drug doses and neuroleptic receptors. Experientia 34, 1490–1492 (1978)
Torrey, E.F., Petersen, M.R.: Schizophrenia and the limbic system. Lancet II: 942–946 (1974)
Trabucchi, M., Cheney, D., Racagni, G., Costa, E.: Involvement of brain cholinergic mechanisms in the action of chlorpromazine. Nature 249, 664–666 (1974)
Trabucchi, M., Cheney, D.L., Racagni, G., Costa, E.: In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine. Brain Res. 85, 130–134 (1975)
Trendelenburg, U., Gravenstein, J.S.: Effect of reserpine pretreatment on stimulation of the ac-celerans nerve of the dog. Science 128, 901–903 (1958)
Udenfriend, S., Weissbach, H., Bogdanksi, D.F.: Increase in tissue serotonin following administration of its precursor 5-hydroxytryptophan. J. Biol. Chem. 224, 803–810 (1957 a)
Udenfriend, S., Weissbach, H., Bogdanski, D.F.: Biochemical findings relating to the action of serotonin. Ann. N. Y. Acad. Sci. 66, 602–608 (1957 b)
Ueda, T., Maeno, H., Greengard, P.: Regulation of endogenous phosphorylation of specific proteins in synaptic membrane fractions from rat brain by adenosine 3′:5′-monophosphate. L Biol. Chem. 248, 8295–8305 (1973)
Ungerstedt, U.: 6-Hydroxy-dopamine induced degeneration of central monoamine neurons. Eur. J. Pharmacol. 5, 107–110 (1968)
Ungerstedt, U.: Sterotaxic mapping of the monoamine pathways in the rat brain. Acta Physiol. Scand. [Suppl.] 367, 1–48 (1971a)
Ungerstedt, U.: Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigrostriatal dopamine system. Acta Physiol. Scand. [Suppl.] 367, 69–93 (1971b)
Ungerstedt, U.: Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the ni-gro-striatal dopamine system. Acta Physiol. Scand. [Suppl.] 367, 95–122 (1971c)
Ungerstedt, U., Pycock, C.: Functional correlates of dopamine neurotransmission. Bull. Schweiz. Akad. Med. Wiss. 30, 44–55 (1974)
Ungerstedt, U., Butcher, L.L., Butcher, S.G., Andén, N.-E., Fuxe, K.: Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461–471 (1969)
Ungerstedt, U., Avemo, A., Avemo, E., Ljungberg, T., Ranje, C.: Animal models of parkinsonism. Adv. Neurol. 3, 257–271 (1973)
Ungerstedt, U., Ljungberg, T., Hoffer, B., Siggins, G.: Dopaminergic supersensitivity in the striatum. Adv. Neurol. 9, 57–65 (1975)
U’prichard, D.C., Snyder, S.H.: 3H-Catecholamine binding to α-receptors in rat brain: enhancement by reserpine. Eur. J. Pharmacol. 51, 145–155 (1978)
Valdman, A.V.: On the localization of the action of chlorpromazine and analgesics in reticular formation of the brain stem. J. Neuropharmacol. 1, 197–200 (1962)
Van der Wende, C., Spoerlein, M.T.: Role of dopaminergic receptors in morphine analgesia and tolerance. Res. Commun. Chem. Path. Pharmacol. 5, 35–43 (1973)
Vogt, M.: The concentration of sympathine in different parts of the central nervous system under normal conditions and after the administration of drugs. J. Physiol. (Lond.) 123, 451–481 (1954)
Vogt, M.: Effect of drugs on metabolism of catecholamines in the brain. Br. Med. Bull. 21, 57–61 (1965)
Vogt, M.: Functional aspects of the role of catecholamines in the nervous system. Br. Med. Bull. 29, 168–172 (1973)
von Voigtlander, P.F., Moore, K.E.: The release of H3-dopamine from cat brain following electrical stimulation of the substantia nigra and caudate nucleus. Neuropharmacology 10, 733–741 (1971)
von Voigtlander, P.F., Moore, K.E.: Involvement of nigrostriatal neurons in the in vivo release of dopamine by amphetamine, amantadine and tyramine. J. Pharmacol. Exp. Ther. 184, 542–552 (1973 a)
von Voigtlander, P.F., Moore, K.E.: Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-Dopa, amantadine, amphetamine and other psychomotor stimulants. Neuropharmacology 12, 451–462 (1973 b)
Waldmeier, P.L., Maitre, L.: On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. L Neurochem. 27, 589–597 (1976)
Walker, J.B.; Walker, LP.: Neurohumoral regulation of adenylate cyclase activity in rat striatum. Brain Res. 54, 386–390 (1973)
Walters, J.R., Roth, R.H.: Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharmacol. Exp. Ther. 191, 82–91 (1974)
Walters, J.R., Bunney, B.S., Roth, R.H.: Piribedil and apomorphine: pre- and postsynaptic effects on dopamine synthesis and neuronal activity. Adv. Neurol. 9, 273–284 (1975)
Walton, K.G., Liepman, P., Baldessarini, R.J.: Inhibition of dopamine stimulated adenylate cyclase activity by phenoxybenzamine. Eur. J. Pharmacol. 52, 231–234 (1978)
Wand, P.: The response of α-motoneurons of different size to stretch and vibration of extensor muscles after injection of 5-hydroxytryptophan in spinal rats. Arch. Ital. Biol. 114, 228–243 (1976)
Wang, S.C.: III. Emetic and antiemetic drugs. Physiol. Pharmacol. 2, 255–328 (1965)
Wang, S.C., Borison, H.L.: A new concept of organization of the central emetic mechanism: recent studies on the sites of action of apomorphine, copper sulfate and cardiac glycosides. Gastroenterology 22, 1–12 (1952)
Wang, S.C., Glaviano, V.V.: Locus of emetic action of morphine and hydergine in dogs. J. Pharmacol. Exp. Ther. 111, 329–334 (1954)
Weber, E.: Ein Rauwolfiaalkaloid in der Psychiatrie: Scine Wirkungsähnlichkeit mit Chlorpro-mazin. Schweiz. Med. Wochenschrift. 84, 968–970 (1954)
Weber, L.J., Horita, A.: A study of 5-hydroxytryptamine formation from L-tryptophan in the brain and other tissues. Biochem. Pharmacol. 14, 1141–1149 (1965)
Webster, R.A.: The antiadrenaline activity of some phenothiazine derivatives. Br. J. Pharmacol. 25, 566–576 (1965)
Weight, F., Salmoiraghi, G.C.: Response of single spinal cord neurons to ACh, NE and 5-HT administered by microelectrophoresis. Pharmacologist 7, 216 (1965)
Weight, F.F., Salmoiraghi, G.C.: Responses of spinal cord interneurons to acetylcholine, norepinephrine and serotonin administered by microelectrophoresis. J. Pharmacol. Exp. Ther. 153, 420–427 (1966 a)
Weight, F.F., Salmoiraghi, G.C.: Adrenergic responses of Renshaw cells. J. Pharmacol. Exp. Ther. 154, 391–397 (1966b)
Weight, F.F., Salmoiraghi, G.C.: Motoneurone depression by norepinephrine. Nature 213, 1229–1230 (1967)
Westerink, B.H.C., Korf, J.: Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur. J. Pharmacol. 38, 281–291 (1976)
Westerink, B.H.C., Lejeune, B., Korf, J., Van Praag, H.M.: On the significance of regional dopamine metabolism in the rat brain for the classification of centrally active drugs. Eur. J. Pharmacol. 42, 179–190 (1977)
Wilson, C.W.M., Brodie, B.B.: The absence of blood-brain barrier from certain areas of the central nervous system. J. Pharmacol. Exp. Ther. 133, 332–334 (1961)
Wilson, C.W.M., Murray, A.W., Titus, E.: The effects of reserpine on uptake of epinephrine in brain and certain areas outside the blood-brain barrier. J. Pharmacol. Exp. Ther. 135, 11–16(1962)
Wilson, V.J.: Effect of intra-arterial injections of adrenaline on spinal extensor and flexor reflexes. Am. J. Physiol. 186, 491–496 (1956)
Windle, W.F., Cammermeyer, J.: Functional and structural observations on chronically reser-pinized monkeys. Science (N.Y.) 127, 1503 (1958)
Windle, W.F., Cammermeyer, J., Joralemon, J.T., Smart, J.O., Feringa, E., McQuillen, M.: Tremor in african green monkeys. Fed. Proc. 15, 202 (1956)
Witkin, L.B., Spitaletta, P., Plummer, A.J.: Effects of some central depressants on two simple reflexes in the mouse. J. Pharmacol. Exp. Ther. 126, 330–333 (1959)
Witkin, L.B., Spitaletta, P., Plummer, A.J.: The effects of some central depressants on spinal reflexes of the intact anesthetized cat. Arch. Int. Pharmacodyn. Ther. 124, 105–115 (1960)
Woodruff, G.N., McCarthy, P.S., Walker, R.J.: Studies on the pharmacology of neurones in the nucleus accumbens of the rat. Brain Res. 115, 233–242 (1976)
Wuerthele, S.M., Moore, K.E.: Studies on the mechanisms of L-DOPA-induced depletion of 5-hydroxytryptamine in the mouse brain. Life Sci. 20, 1675–1680 (1977)
Yaksh, T.L., Rudy, T.A.: Analgesia mediated by a direct spinal action of narcotics. Science 192, 1357–1358 (1976)
Yaksh, T.L., Rudy, T.A.: Studies on the direct spinal action of narcotics in the production of analgesia in the rat. J. Pharmacol. Exp. Ther. 202, 411–428 (1977)
Yaksh, T.L., Yamamura, H.I.: Depression by morphine of the resting and evoked release of [3H]-acetylcholine from the cat caudate nucleus in vivo. Neuropharmacology 16, 227–233 (1977)
Yamaguchi, N., Ling, G.M., Marczynski, T.J.: The effects of chemical stimulation of the preoptic region, nucleus centralis medialis or brain stem reticular formation with regard to sleep and wakefulness. Recent Adv. Biol. Psychiatr. 6, 9–20 (1964)
York, D.H.: Possible dopaminergic pathway from substantia nigra to putamen. Brain Res. 20, 233–249 (1970)
York, D.H.: Dopamine receptor blockade — a central action of chlorpromazine on striatal neurones. Brain Res. 37, 91–99 (1972 a)
York, D.H.: Potentiation of lumbo-sacral monosynaptic reflexes by the substantia nigra. Exp. Neurol. 36, 437–448 (1972 b)
York, D.H.: Motor responses induced by stimulation of the substantia nigra. Exp. Neurol. 41, 323–330 (1973 a)
York, D.H.: Antagonism of descending effects of the substantia nigra on lumbo-sacral monosynaptic reflexes. Neuropharmacology 12, 629–636 (1973 b)
Yoshida, M., Precht, W.: Monosynaptic inhibition of neurons of the substantia nigra by caudato-nigral fibers. Brain Res. 32, 225–227 (1971)
Zieglgänsberger, W., Bayerl, H.: The mechanism of inhibition of neuronal activity by opiates in the spinal cord. Brain Res. 115, 111–128 (1976)
Zieglgänsberger, W., Satoh, M.: The mechanism of inhibition by morphine on spinal neurones of the cat. Exp. Brain. Res. 23, 444 (1975)
Zivkovic, B., Guidotti, A., Revuelta, A., Costa, E.: Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens. J. Pharmacol. Exp. Ther. 194, 37–46 (1975)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Jurna, I. (1980). Neurophysiological Properties of Neuroleptic Agents in Animals. In: Hoffmeister, F., Stille, G. (eds) Psychotropic Agents. Handbook of Experimental Pharmacology, vol 55 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67538-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-67538-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67540-9
Online ISBN: 978-3-642-67538-6
eBook Packages: Springer Book Archive